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ABSTRACT 
 
Cortical Thickness Abnormalities within the Salience and Reward Networks in Older 
Depressed Adults with Apathy 
by 
Monique A. Pimontel 
 
Advisor: Joel Sneed, Ph.D. 
 
Background and Significance  
 Apathy is a common comorbidity in late-life depression. Among older depressed adults, 
apathy is associated with a number of adverse outcomes, including increased disability, 
comorbid illness, and mortality. The etiological substrates of apathy in late-life depression 
nonetheless remain poorly understood, and little is known about its optimal treatment. To this 
end, the aim of the current study was to examine cortical abnormalities within the salience (SN) 
and reward networks (RN), two brain systems involved in the processing of incentive salience 
that may underlie the syndrome of apathy in older depressed adults.  
 
Methods  
 We examined the association between apathy and cortical thickness of the right insula, 
caudal anterior cingulate cortex (cACC), rostral anterior cingulate cortex (rACC), medial 
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orbitofrontal cortex (mOFC), and lateral orbitofrontal cortex (lOFC) in 49 individuals with late-
life depression before and after 12 weeks of antidepressant treatment with the selective serotonin 
reuptake inhibitor (SSRI) escitalopram. Apathy was quantified using the Apathy Evaluation 
Scale (AES). Cortical thickness was computed using FreeSurfer. Regions of interest (ROIs) were 
parcellated using the Desikan-Killiany atlas.  
 
Results 
 Within the SN, cortical thickness of the insula was significantly associated with response 
of apathy symptoms to escitalopram, as well as persistence of apathy symptoms after 12 weeks 
of treatment. Thickness of the cACC, which is involved in both salience and reward processing, 
was not associated with apathy at any time. Within the RN, thickness of the rACC was 
significantly related to apathy at baseline. Thickness of the mOFC and lOFC was not associated 
with apathy at any time. Exploratory analyses examining the association between cognitive 
functions and apathy revealed a relationship between response of apathy to treatment and several 
aspects of cognition, including processing speed, executive functioning (i.e., set shifting and 
source monitoring), and memory (i.e., retrieval of verbal information).  
 
Conclusions 
 The results of this study suggest a role for abnormalities within both the SN and RN in 
older depressed adults with apathy. Given the interplay between structures of the SN and RN in 
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processing of incentive salience, older depressed adults with apathy may have a decreased ability 
to associate an anticipated outcome with the experience of desire, thereby decreasing motivated, 
goal-directed activity. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 	  	  	  
	  	  	  	  
vii 
TABLE OF CONTENTS   
INTRODUCTION   
I. APATHY  
 Epidemiology   1 
 Clinical Significance   2 
 Apathy and Late-Life Depression   5 
 Conceptual Theories    7 
 Neuroanatomical Abnormalities    8 
II. THE SALIENCE NETWORK 
 Function    13 
 Neuroanatomy    14 
 The Role of the SN in Apathy   18 
III. THE REWARD NETWORK  
 Function   19 
 Neuroanatomy    19 
 The Role of the RN in Apathy    24 
IV. INCENTIVE SALIENCE    25 
V. CORTICAL THICKNESS    
 The Cerebral Cortex     26 
 Measuring Cortical Thickness    28 
 	  	  	  
	  	  	  	  
viii 
VI. AIMS AND HYPOTHESES   29 
METHODS    
I. PARTICIPANTS   31 
II. ASSESSMENT   32 
III. TREATMENT   38 
IV. MRI PROCEDURES   38 
V. DATA ANALYSIS   41 
RESULTS  
I. MISSING DATA   45 
II. OUTLIER ANALYSES   46 
III. DEMOGRAPHIC AND CLINICAL CHARACTERISTICS   47 
IV. ANTIDEPRESSANT TREATMENT RESPONSE     48 
V. STRUCTURAL ABNORMALITIES WITHIN THE SN     
Baseline        49 
Week 12        50 
Change in Apathy Severity      52 
VI. STRUCTURAL ABNORMALITIES WITHIN THE RN   
Baseline        53 
Week 12        54 
Change in Apathy Severity      56  
 	  	  	  
	  	  	  	  
ix 
VII. COGNITIVE FUNCTIONING  
Baseline        57 
Week 12        58 
Change in Apathy Severity      59  
DISCUSSION 
I. MAIN FINDINGS       62 
II. APATHY AND LATE-LIFE DEPRESSION    63 
III. CORTICAL THICKNESS      64 
IV. COGNITIVE FUNCTIONING      68 
V. CLINICAL IMPLICATIONS      75 
VI. LIMITATIONS        78 
VII. FUTURE DIRECTIONS       79 
VIII. CONCLUSION        83 
APPENDICES 
A. TABLES AND GRAPHS      84 
B. FIGURES        102 
REFERENCES         110 
 
 	  
 	  	  	  
	  	  	  	  
x 
APPENDIX A 
TABLES AND GRAPHS 
TABLES   
Table 1. Key study variable for all study participants    84 
Table 2. Key study variables at baseline       85 
Table 3. Hierarchical linear regression predicting baseline apathy severity   86 
Table 4. Hierarchical linear regression predicting week 12 apathy severity   88 
Table 5. Hierarchical linear regression predicting change in apathy severity  90 
Table 6. Hierarchical linear regression predicting baseline apathy severity   92 
Table 7. Hierarchical linear regression predicting week 12 apathy severity  94 
Table 8. Hierarchical linear regression predicting change in apathy severity  96 
Table 9. Hierarchical linear regression predicting baseline apathy severity   98 
Table 10. Hierarchical linear regression predicting week 12 apathy severity  99 
Table 11. Hierarchical linear regression predicting change in apathy severity  100 
Table 12. Hierarchical linear regression predicting change in apathy severity  101 
 
GRAPHS 
Graph 1. Scatterplot of Salience Network and AES Baseline   87 
 	  	  	  
	  	  	  	  
xi 
Graph 2. Scatterplot of Salience Network ROIs and AES Week 12   89 
Graph 3. Scatterplot of SN ROIs and AES Change     91 
Graph 4. Scatterplot of RN ROIs and AES Baseline    93 
Graph 5. Scatterplot of RN ROIs and AES Week 12    95 
Graph 6. Scatterplot of RN ROIs and AES Change     97 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 	  	  	  
	  	  	  	  
xii 
APPENDIX B 
FIGURES 
Figure 1. Differences and similarities between symptoms of apathy and depression  102 
Figure 2. Proposed diagnostic criteria for apathy     103 
Figure 3. Key nodes in the Salience Network     104 
Figure 4. The Salience Network       105 
Figure 5. Key nodes in the Reward Network     106 
Figure 6. The Reward Network       107 
Figure 7. Incentive Salience Processing       108 
Figure 8. Cortical ROI parcellations in the Desikan-Killiany atlas    109
 	  	  	  	  	  	  	  	  	  	  
 	  	  	  
	  	  	  	  
1 
INTRODUCTION 
I. APATHY 
Epidemiology 
 Apathy is defined as a decrease in self-motivated, goal-directed activity (Stuss et al., 
2000; Levy and Dubois, 2006). Although apathy was originally viewed simply as a symptom or 
dimension of behavior, it is currently considered a clinical syndrome that may reflect a number 
of affective, cognitive, and behavioral disturbances, including emotional indifference or blunting, 
an inability to formulate or sequence a purposeful plan of action, and an inability to initiate 
behavior necessary for attaining a goal (Marin, 1991; Robert et al., 2009). Although symptoms of 
apathy may be experienced by individuals who are otherwise healthy (Brodaty et al., 2010),  
apathy more commonly occurs in the context of a wide-variety of other neuropsychiatric 
disorders (Marin, 1991; van Reekum et al., 2005), such as dementia (Starkstein et al., 2006), 
Parkinson’s disease (PD) (Starkstein et al., 1992), schizophrenia (Roth et al., 2007), and 
depression (Marin et al., 1993).  
The prevalence of apathy increases with age (Starkstein et al., 1993; Onyike et al., 2007), 
and appears to be the most commonly observed behavioral disturbance in demented older adults 
living in nursing homes (Zuidema et al., 2007). Among non-demented, community-dwelling 
elderly, those with late-life depression are most susceptible to apathy (Lampe and Heeren, 2004; 
Onyike et al., 2007; Mehta et al., 2008; Groeneweg-Koolhoven et al., 2015). For example, in one 
study of 476 non-demented, community-dwelling older adults, apathy was present in 75% of 
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individuals with major depression, while only 25% of their non-depressed counterparts reported 
symptoms of apathy (Groeneweg-Koolhoven et al., 2015).  Two studies examining apathy and 
late-life depression in inpatients have found comorbidity rates ranging from 74% to 96% (Lampe 
and Heeren, 2004; Wongpakaran et al., 2007), whereas studies examining the prevalence of 
apathy in non-depressed older adults have found apathy rates ranging from 7.5% of outpatients 
visiting their primary care physician (Groeneweg-Koolhoven et al., 2014) to 53% of individuals 
with vascular disease (Ligthart et al., 2012). Thus, although the prevalence of apathy varies, 
apathy nonetheless appears to occur most commonly in the context of late-life depression.  
 
Clinical Significance 
Apathy is associated with many facets of decreased quality of life. For example, a recent study of 
937 community-dwelling, non-demented older adults revealed an association between apathy 
and increased risk of developing slow gait, frailty, and disability after adjustment for 
demographic characteristics, medical comorbidities, and cognitive functioning (Ayers et al., 
2017). Similarly, in a sample of 1,136 community-dwelling adults aged 50 and older, apathy was 
associated with cognitive decline and a decrease in both instrumental and basic activities of daily 
life after a one-year follow up, even after accounting for age, education, race, and depression 
(Clarke et al., 2010). Associations have also been found between apathy, increased functional 
impairment, unemployment, and decreased quality of life  (Starkstein et al., 1993; Onyike et al., 
2007; Reyes et al., 2009; Hölttä et al., 2012; Groeneweg-Koolhoven et al., 2014). Compared to 
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their non-apathetic counterparts, individuals with apathy have higher frequencies of cognitive 
impairment, cognitive decline, and dementia, as well as other neuropsychiatric disorders and 
medical comorbidities (Doody et al., 1995; Levy et al., 1998; Clarke et al., 2010; Hölttä et al., 
2012). Apathy is associated with high caregiver burden (Kaufer et al., 1998); in fact, in one 
study, caregivers of individuals with dementia rated apathy as being the most challenging 
behavior to manage, secondary to their decreased engagement in even basic activities of daily 
living (Thomas et al., 2001). In addition, apathetic individuals are less likely to be compliant 
with and respond to treatment for comorbid illnesses (Kopelowicz et al., 1997; Mega et al., 1999; 
Tattan and Creed, 2001). Finally, apathy is associated with higher frequencies of hospital 
admission and mortality (Levy et al., 1998; Hölttä et al., 2012).  
Older adults with apathy and comorbid depression are at a particularly high risk of poor 
clinical outcome. For example, depression severity is higher in older adults with comorbid 
apathy when compared to their non-apathetic counterparts (Yuen et al., 2014). Depression is 
more chronic in those with comorbid apathy (Chaturvedi and Sarmukaddam, 1986), as 
demonstrated by a longitudinal study of 16 individuals with late-life depression that revealed an 
association between apathy and chronicity of depression after a 6-year follow up (Lavretsky et 
al., 1999). Apathetic individuals with late-life depression are also less likely to respond to 
antidepressant treatment than their non-apathetic counterparts (Lavretsky et al., 1999; Levkovitz 
et al., 2011; Yuen et al., 2014). In a study of 62 depressed individuals ages 18 to 65, apathy 
severity was significantly correlated with persistence of depressive symptoms following a month 
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of five weekly treatments with deep transcranial magnetic stimulation over the prefrontal cortex 
(Levkovitz et al., 2011).  
Despite the wide-range of aforementioned adversities that are associated with the 
syndrome, apathy is frequently left undiagnosed and untreated (Chase, 2011). Apathetic 
individuals often lack concern and self-awareness of impairment, and may significantly 
underestimate the severity of their symptoms (Derouesné et al., 1999; Mograbi and Morris, 
2014). For example, in a study examining apathy and awareness in Alzheimer’s disease (AD), 
patients’ ratings of symptom severity was equivalent to that of control participants, whereas 
caregiver reports revealed significantly higher apathy scores for individuals with AD when 
compared to controls (Robert et al., 2002). Additionally, given frequent overlap with medical 
illness, there is a higher likelihood that apathetic individuals will seek medical care than mental 
health services. Older depressed adults are at a particularly high risk of somatization, while 
denying mood disturbances or behavioral changes (Gallo et al., 1999; Lampe and Heeren, 2004). 
Physicians may mistakenly assume that apathy in late-life is an unavoidable consequence of 
medical illness or environmental circumstances, and as such, they may approach apathy as a 
benign behavioral condition (Chase, 2011). Furthermore, in these individuals, apathy may be 
seen as a symptom of depression, as opposed to a syndrome that requires its own targeted 
treatment (Yuen et al., 2014). As a result, apathy continues to pose a significant burden on older 
adults with late-life depression, as well as on their caregivers and society-at-large.  
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Apathy and Late-Life Depression 
 Despite the frequent co-occurrence of apathy with depression, as well as a significant 
overlap in symptoms, apathy and depression are nonetheless distinct entities (Marin, 1991; Marin 
et al., 1993; Levy et al., 1998; Reyes et al., 2009; Njomboro and Deb, 2012; Pardini et al., 2016). 
Studies examining apathy and depression have found that while individuals with apathy are 
likely to have comorbid depression, a significant number of individuals have apathy in the 
absence of depression. For example, in a study examining apathy and depression in PD, 
depressive symptoms were absent in 12% of individuals with apathy (Starkstein et al., 1992). In 
another study examining apathy and depression in post-stroke individuals, 30% were found to 
have apathy, but not depression  (Okada et al., 1997). Furthermore, another study found that 
although apathy was present in 86% of elderly, depressed inpatients, structured clinical ratings of 
apathy severity were not associated with structured clinical ratings of overall depression severity  
(Lampe and Heeren, 2004).   
 Clinically, there are discrepancies between the behavioral expression of apathy and 
depression (Figure 1) (Levy et al., 1998; Lavretsky et al., 2007). Most notably, individuals with 
apathy often do not present with dysphoric symptoms such as sad mood, guilt, and hopelessness, 
while these symptoms are core features of major depression (Marin et al., 1993). In addition, 
symptoms of apathy and depression respond differently to treatment with antidepressant 
medication (Raskin et al., 2012; Yuen et al., 2014), such that apathy often persists despite 
resolution of depressive symptoms (Yuen et al., 2014). For example, in one study, 43% of non-
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demented, apathetic older adults continued to have clinically significant symptoms of apathy 
following 12 weeks of antidepressant treatment with a selective serotonin reuptake inhibitor 
(SSRI), despite improvement in depressive symptoms (Yuen et al., 2014). In another study, 
32.5% of middle-aged participants with remitted depression continued to report symptoms of 
apathy following three months of antidepressant treatment (Fava et al., 2006).    
 Studies examining the neuroanatomical abnormalities underlying apathy and depression 
provide further evidence for a distinction between these two disorders (Marin et al., 1993; 
Starkstein et al., 1993; Onoda and Yamaguchi, 2015). One diffusion tensor imaging (DTI) study 
examining apathy and depression in middle-aged and older adults with small vessel disease 
found that apathy, but not depression, was related to disruptions in limbic association tracts such 
as the anterior cingulum, fornix and uncinate fasciculus (Hollocks et al., 2015). A magnetic 
resonance imaging (MRI) study of older depressed adults with apathy revealed an association 
between apathy severity and decreased gray matter volume of the right anterior cingulate cortex 
(ACC) after controlling for age and sex, while depression severity was associated with decreased 
gray matter volume of the bilateral orbitofrontal cortex (OFC) (Lavretsky et al., 2007). In a study 
of individuals with HIV, a correlation was found between apathy and decreased volume of the 
nucleus accumbens (NAcc), while this correlation was not found with depression (Paul et al., 
2005). Finally, different neuroanatomical substrates are associated with antidepressant treatment 
response of apathetic and depressive symptoms. Persistence of apathy following SSRI treatment 
is associated with smaller left posterior subgenual cingulate volume and decreased integrity of 
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the left uncinate fasciculus (Yuen et al., 2014), whereas nonresponse of depressive symptoms to 
SSRI is associated with gray matter volume of the dorsal (dACC) and rostral anterior cingulate 
(rACC) (Starkstein et al., 2001), but not with subgenual cingulate volume (Gunning et al., 2009).   
 In conclusion, while apathy frequently co-occurs with late-life depression and was 
historically considered a hallmark symptom (Groeneweg-Koolhoven et al., 2015), their distinct 
clinical characteristics and separable neuroanatomical abnormalities suggest that apathy and late-
life depression may be overlapping, albeit dissociable entities (Marin, 1991; Marin et al., 1993; 
Levy et al., 1998; Reyes et al., 2009; Njomboro and Deb, 2012; Pardini et al., 2016). Even so, 
apathy in late-life depression remains under-recognized, and the typical approach to treating 
apathy symptoms in older depressed adults with antidepressant medication is inadequate (van 
Reekum et al., 2005).  Developing a better understanding of the syndrome of apathy and 
elucidating its specific etiological abnormalities are crucial steps toward identifying more 
effective treatments for the disturbances associated with apathy in older depressed adults. 
 
Conceptual Theories 
 Apathy is most commonly defined as a “diminished motivation not attributable to a 
decreased level of consciousness, cognitive impairment, or emotional distress” (Marin et al., 
1991). However, given that motivation is a subjective experience, others have advocated for a 
more easily measured, objective conceptualization of apathy (Levy and Czernecki, 2006). For 
example, apathy has been defined as “an absence of responsiveness to stimuli as demonstrated 
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by a lack of self-initiated action,” which may originate from changes in affective, behavioral, or 
cognitive functioning (Stuss et al., 2000). Others have similarly proposed that apathy be defined 
as “an observable behavioral syndrome consisting of a quantitative reduction in voluntary (or 
goal-directed) behaviors” (Levy and Czernecki, 2006). 
 Given the differing definitions of apathy, a task force was assembled in 2009 that 
combined the aforementioned conceptualizations into diagnostic criteria that could aid the 
diagnosis of apathy in both clinical practice and research (Robert et al., 2009; Mulin et al., 2011). 
As per these criteria (Figure 2), an individual must experience a decrease in motivation for at 
least four weeks. At least two of three objective dimensions of apathy must be present, including 
reduced voluntary and purposeful behavior, decreased goal-directed cognitive activity, and/or 
emotional indifference or blunting. Furthermore, an individual must experience identifiable 
functional impairment that can be attributed directly to a decline in motivation. Finally, the 
individual must not meet criteria for other, related diagnoses, such as abulia, akinesia and 
akinetic mutism, depression, dementia, delirium, and anxiety (Mann, 1990). 
 
Neuroanatomical Abnormalities   
 Motivated, goal-directed behavior requires integration of sensory inputs, emotional 
information, and memories of prior events, as well as attribution of motivational valence to 
stimuli, formulation of a plan of action, and initiation of action (Haber, 2011). These functions 
are associated with fronto-subcortical networks, including regions within the frontal cortex and 
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basal ganglia (van Reekum et al., 2005; Levy and Czernecki, 2006; Levy, 2012). Consistent with 
its hallmark clinical features of decreased motivation and goal-directed behavior, apathy is 
associated with disturbances in these fronto-subcortical networks (Levy and Czernecki, 2006; 
Levy and Dubois, 2006; Levy, 2012; Hollocks et al., 2015; Moretti and Signori, 2016). 
Furthermore, there is evidence of lateralized involvement in apathy, such that apathy is 
associated more strongly with disturbances in the right hemisphere, as compared to the left 
hemisphere. For example, an MRI study of individuals with late-life depression found decreased 
gray matter volume in the right, but not the left, ACC (Lavretsky et al., 2007), while another 
MRI found increased resting-state functional connectivity (rsFC) only between the right anterior 
insula (AI) and the right dorsolateral prefrontal cortex (DLPFC) in older depressed adults with 
apathy (Yuen et al., 2014). In addition, individuals with right-hemisphere stroke have a greater 
propensity toward the development of apathy than those with left-hemisphere stroke (Marin et 
al., 1994).  
 Involvement of fronto-subcortical areas has been well documented in studies examining 
apathy in older adults with dementia. For example, apathy is prominent in neurodegenerative 
disorders with frontosubcortical involvement, such as Huntington’s disease, Lewy-Body disease 
(LBD), progressive supranuclear palsy, and PD (Starkstein et al., 2006; Chase, 2011; Quaranta et 
al., 2012). In fact, apathy is one of the most common neuropsychiatric symptoms in PD 
(Alzahrani et al., 2016), and in these individuals, apathy is associated with lower gray matter 
volume in several brain areas including the left insula, left frontal gyrus, right anterior cingulate, 
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and left superior temporal gyrus. Apathy is relatively uncommon in cortical dementias such AD 
(Paulsen et al., 1996; Hargrave et al., 2000). However, there is nonetheless evidence that 
individuals with AD who have neurofibrillary tangles in the ACC are more likely to suffer from 
apathy than individuals with AD pathology predominant in other areas (Tekin et al., 2001; 
Marshall et al., 2006) 
 Further evidence for the involvement of fronto-subcortical brain regions comes from 
studies examining apathy in individuals with focal lesions. Apathy is common in individuals 
with focal damage to the frontal lobe (Levy et al., 1998; Marsh and Hicks, 1998). However, there 
is conflicting evidence regarding the exact locations within the frontal lobe that are involved in 
apathy. For example, one study demonstrated that apathy is more common in individuals with 
lateral frontal lobe lesions as opposed to those with lesions in the medial frontal lobe (Paradiso et 
al., 1999). In contrast, another study found that individuals with ventromedial lesions of the 
frontal lobe were more likely to suffer from apathy than individuals with lesions in other areas of 
the frontal lobe (Barrash et al., 2000).  
  Neuroimaging studies examining the neuroanatomical abnormalities associated with 
apathy in various populations have also found indication of fronto-subcortical involvement. 
Within the frontal lobe, abnormalities have been identified in the middle and inferior frontal gyri 
(Yan et al., 2015). Within the basal ganglia, structural abnormalities have been found in the 
putamen, NAcc, internal capsule, and caudate nucleus (Starkstein et al., 1993; Bruen et al., 2008; 
Martínez-Horta et al., 2014; Yan et al., 2015; Kazui et al., 2017). 
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 Imaging studies have also identified abnormalities in the ACC and in the temporal lobe in 
individuals with apathy. Apathy severity correlates with reduced gray matter volume and 
metabolic activity in both anterior and posterior areas of the ACC (Migneco et al., 2001; 
Apostolova et al., 2007; Lanctôt et al., 2007; Lavretsky et al., 2007; Marshall et al., 2007; Bruen 
et al., 2008; Starkstein et al., 2009; Tunnard et al., 2011; Stella et al., 2014; Huey et al., 2017). 
Within the temporal lobe, apathy is associated with abnormalities of the superior temporal sulcus 
and fusiform gyrus (Ott et al., 1995; Alzahrani et al., 2016; Huey et al., 2017; Kazui et al., 2017).  
Several studies have identified abnormalities of the AI in individuals with apathy. In 
older depressed adults, apathy is associated with increased functional resting-state connectivity 
between the right AI and right DLPFC (Yuen et al., 2014). Apathy is also common in individuals 
with insular lesions in brain-damaged patients (Njomboro et al., 2012). Apathy in PD is 
characterized by lower gray matter volume in the left insula (Alzahrani et al., 2016), and lesion 
mapping in individuals with traumatic brain injuries has also revealed abnormalities in the left 
insula (Knutson et al., 2014). Finally, positron emission tomography (PET) imaging in AD has 
revealed correlations between apathy and abnormalities in the bilateral insula (Mori et al., 2014).  
Evidence for the involvement of fronto-subcortical brain regions in apathy also comes 
from studies examining the neurocognitive functioning of individuals with apathy. Apathy is 
often conceptualized as a behavioral manifestation of executive dysfunction (Kuzis et al., 1999; 
Drijgers et al., 2011). Executive functioning refers to a broad class of mental functions necessary 
for adaptive and goal-directed behavior that includes planning, organization, problem-solving, 
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mental flexibility, and response inhibition (Miyake et al., 2000; Stuss and Alexander, 2000), and 
these aspects of cognition are associated with disturbances in fronto-subcortical networks 
(Bonelli and Cummings, 2007). Not surprisingly, studies delineating the neuropsychological 
profile of individuals suffering from apathy have consistently found prominent executive 
dysfunction (Alzahrani et al., 2016), including impaired set shifting (Kuzis et al., 1999; Feil et 
al., 2003; Onyike et al., 2007), cognitive inhibition (Feil et al., 2003), working memory 
(Zgaljardic et al., 2007), conceptualization (Zgaljardic et al., 2007), and verbal fluency (Kuzis et 
al., 1999; Feil et al., 2003; Onyike et al., 2007; Zgaljardic et al., 2007; Drijgers et al., 2011). In 
addition, impairments in executive control processes that underlie memory (Robert et al., 2006) 
and word retrieval (Kuzis et al., 1999) have also been reported in older adults with apathy.  
 Taken together, there is ample evidence for the involvement of fronto-subcortical 
structures in apathy. These structures primarily contribute to motor, cognitive, and behavioral 
functions within the brain (Bonelli and Cummings, 2007). Disruptions of fronto-subcortical 
circuits may result in executive dysfunction, personality changes such as disinhibition, emotional 
lability, and lack of empathy, and the formulation, execution, and mediation of behavior in 
response to physiological, emotional, and environmental cues (Bonelli and Cummings, 2007). 
This suggests that the decrease in volitional and goal-directed activity that defines apathy may be 
associated with impairments in processing internal and external stimuli, regulating emotions, and 
integrating these cues into goals and behavior conducive to attainment of these goals (Levy and 
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Czernecki, 2006; Levy and Dubois, 2006; Levy, 2012; Hollocks et al., 2015; Moretti and 
Signori, 2016).  
 
II. THE SALIENCE NETWORK 
Function 
 Apathy has been associated with several focal areas in the brain (see Neuroanatomical 
Abnormalities). However, none of these brain areas function in isolation. Approaching complex 
constructs such as apathy from a network perspective allows a more dynamic and holistic 
approach to understanding the intricate brain mechanisms that give rise to such a phenomenon. 
One brain network that has been associated with motivation is the salience network (SN). The 
SN mediates stimulus-driven, bottom-up control of attention (Uddin, 2015) by identifying 
stimuli that are “infrequent in space or time, or have learned or instinctive biological importance, 
including those that are pleasurable and rewarding, self-relevant, or emotionally engaging” 
among the abundance of sensory input that is processed by the brain (Knutson and Greer, 2008; 
Menon, 2015; Uddin, 2015). In other words, the SN detects internal states and external stimuli 
that are relevant for the optimal functioning of an individual (Menon and Uddin, 2010). In turn, 
the SN activates other networks that adjust homeostatic states, emotional experiences, cognitive 
processes, and overt behaviors in order to maintain goal-directed behavior (Dosenbach et al., 
2007; Menon and Uddin, 2010; Gradin et al., 2013). For example, in the right hemisphere, the 
SN plays a key role in disengaging the default mode network (DMN) and activating the 
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cognitive control network (CCN) (Menon and Uddin, 2010). Failed attribution or misattribution 
of salience may therefore interfere with goal-directed activity, and this may be a crucial 
component underlying the absence of motivation in apathy (Berridge et al., 2009). 
 
Neuroanatomy 
 The SN consists of several interconnected brain structures that play a key role in 
integrating external sensory information with internal emotional, cognitive, and physiologic 
signals (Menon and Uddin, 2010), particularly in the right hemisphere (Cauda et al., 2011). The 
main structures associated with salience processing are the insula and dACC (Figure 3). In 
addition, salience processing is associated with three subcortical structures, including the 
amygdala, ventral striatum, and substantia nigra (Menon, 2015; Uddin, 2015).  
 The insula lies deep within the lateral sulcus (Cauda et al., 2011), and serves to identify 
stimuli that are relevant for goal-directed activity among the myriad of internal and external 
inputs that compete for attention at any given moment. For example, during tasks that require an 
individual to respond to infrequently occurring target items presented among more frequently 
occurring distractor items (i.e., oddball tasks), the insula consistently shows greater activation in 
response to target items (Uddin, 2015). In order to fulfill its function, the insula predominantly 
receives multimodal sensory input, for example from the primary somatosensory cortex, 
olfactory cortex, and superior temporal sulcus, as well as from structures that govern memory, 
emotion, and reward processing (Menon and Uddin, 2010). In contrast, the insula produces little 
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motor output, but rather has efferent connections to areas such as the dorsolateral prefrontal 
cortex (DLPFC) and OFC (Menon and Uddin, 2010).  
 The insula is cytoarchitectonically divided into three regions (Cauda et al., 2011; 
Stephani et al., 2011). Specifically, the insula consists of an anterior, agranular region, which is 
connected both functionally and anatomically to a posterior granular area via a transitional 
dysgranual area (Cauda et al., 2011). The posterior insula (PI) receives interoceptive input such 
as pain, itch, touch, and the sensation of warm and cold, which it uses to inform other areas of 
the brain that serve to maintain physiological homeostasis. While the AI is also involved in 
maintaining physiological homeostasis, it has an added role of processing external and affective 
input. Specifically, the AI receives communications regarding interoceptive states from the PI 
and other sensory areas, and consolidates this input with information regarding the external 
environment, emotional states, and memories (Craig, 2002; Critchley et al., 2004; Singer et al., 
2009; Lamm et al., 2011). As an example, while the PI is only activated when an individual 
receives a painful stimulus, the AI is also activated when an individual witnesses another person 
in pain (Singer et al., 2004).  
 The functional distinctions between the AI and PI suggest a more prominent role for the 
AI in functions subsumed by the SN. The AI is activated by a wide variety of tasks involving the 
subjective awareness of external events that may have a positive or negative effect on goal 
attainment (Craig, 2002). For example, the AI is activated by prosocial cues that elicit 
experiences such as love and trust, as well as by situations that involve social error, such as when 
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there is a sudden change in the emotional state of another individual in the environment (Allman 
et al., 2010). In mothers, the AI is activated in response to the sound of a crying infant (Allman 
et al., 2010). The AI is also activated during experiences of resentment, embarrassment, and guilt 
(Allman et al., 2010). Furthermore, the AI is activated during tasks that require social judgment, 
such as when an individual is asked to describe a person’s intentions based on facial expressions 
(Baron-Cohen et al., 1999), when empathy is elicited (Singer, 2006), and when an individual is 
exposed to another’s malevolent intentions, such as dishonesty or deceit (Baumgartner et al., 
2009; Baumgartner et al., 2013). Finally, the AI is activated in response to negative feedback 
signaling the need for behavioral regulation (Ullsperger et al., 2010), for example, when a loss is 
anticipated or experienced during a gambling task (Preuschoff et al., 2008; Jones et al., 2011).   
 The dACC consists of Brodmann area 32, and comprises a section of the cingulate cortex 
that surrounds the anterior aspect of the corpus callosum (Cauda et al., 2011). In contrast to the 
AI, the dACC receives little sensory input, and instead has strong connections to areas that 
subsume executive control of cognition, emotion, and motor function, including the DLFC and 
premotor cortex (Mansouri et al., 2009). This allows it to fulfill its primary function of conflict 
monitoring and response selection (Ide et al., 2013). In the context of the SN, the dACC monitors 
for salient stimuli that conflict with goal-directed action (Posner and DiGirolamo, 1998; Bush et 
al., 2000; Paus, 2001; Walton et al., 2003; Vogt, 2005).  Upon detection of information that 
signals a conflict, the dACC evaluates the potential rewards and losses associated with that 
conflict, and initiates the most favorable solution by activating other brain networks, such as the 
 	  	  	  
	  	  	  	  
17 
CCN and motor system. The dACC monitors for conflict in both internal states and external 
events. For example, the dACC is activated when an individual is exposed to competing stimuli 
that require cognitive inhibition of a preponderant response (Braver et al., 2001; Albert et al., 
2012), such as during signal tasks in which a prepotent response must be inhibited to allow 
response with a less intuitive response (Manza et al., 2016).    
 The AI and dACC are connected by specialized neurons present only in these brain 
structures (Allman et al., 2010). These neurons, known as spindle cells or von Economo neurons 
(VENs) (Sarter et al., 2001), are found only in humans, gorillas, chimpanzees, and bonobos. 
VENs are morphologically distinct, with large cell bodies, prominent axons, a simplified 
dendritic tree, and a spindled appearance. This morphology facilitates their function, such that 
VENs are able to rapidly integrate and transmit small amounts of specific information to distant 
parts of the brain through dopaminergic and serotonergic transmission (Butti et al., 2013; Allman 
et al., 2010). In contrast, neighboring pyramidal neurons are responsible for sending more 
detailed information, and transmission of information from these neurons occurs at a slower pace 
(Butti et al., 2013). In infants, the number of VENs is equal in both hemispheres. While a 
hemispheric balance remains into adulthood in the ACC, the number of VENs in adults is higher 
in the right than the left AI (Allman et al., 2010).  
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The Role of the SN in Apathy 
 Evidence for the involvement of the SN in apathy comes from both human and animal 
studies. First, neuroanatomical abnormalities within the AI and ACC are associated with apathy 
(Migneco et al., 2001; Benoit et al., 2002; Alzahrani et al., 2016). A recent resting-state fMRI 
study of older depressed adults with apathy revealed an association between apathy and 
decreased connectivity within the SN, including the right AI and dACC (Yuen et al., 2014). In an 
fMRI study with a partially overlapping sample, apathy in late-life depression was associated 
with changes in resting-state connectivity between the insula, dACC, and a variety of subcortical 
structures (Alexopoulos et al., 2013). In addition, electrical brain stimulation of areas within the 
SN elicits a sense of motivation and “the expectation of an imminent challenge coupled with a 
determined attitude to overcome it” (Parvizi et al., 2013). Finally, in animal studies, rodents with 
lesions in the SN give up more easily when required to climb over a barrier in order to reach a 
food pellet (Rudebeck et al., 2006). 
 In sum, given the role of the SN in processing and responding to motivationally relevant 
stimuli, as well as findings associating apathy with the brain areas involved in salience 
processing, it is possible that the SN is associated with the motivational deficits that underlie 
apathy. As such, apathy might be the consequence of decreased awareness of salient events that 
are relevant for goal-directed behavior. 
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III. THE REWARD NETWORK 
Function 
 In addition to salience processing, brain regions commonly associated with apathy are 
also involved in reward processing. As such, another network that may be disrupted in 
individuals with apathy is the reward network (RN). Indeed, a key component to self-motivated 
behavior is the attribution of a potential reward to a future goal (Haber, 2011). The role of the 
RN can be separated into three steps (Haber, 2011). First, the RN integrates incoming sensory 
information with emotional valence and memories of prior outcomes in order to determine the 
value of current or anticipated rewards and losses. Second, the RN activates cognitive networks 
to determine potential responses and select the most optimal option. Finally, the RN activates 
networks that subsume control of cognition, motor function, emotions, and homeostasis in order 
to implement the selected response (Haber, 2011).  
 
 Neuroanatomy 
 The RN consists of a complex network of cortical and subcortical structures. At the 
center of the RN are the OFC, ACC, thalamus, and basal ganglia (Haber, 2011; Liu et al., 2011). 
While subcortical structures are involved in attaining goals that satisfy basic needs, cortical 
structures are more strongly associated with abstract motivators such as money, power, or 
challenge (Haber, 2011). The ACC and OFC mediate different aspects of reward-based 
behaviors, including error prediction, value attribution, and the choice between short- and long-
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term gains. Specifically, the OFC attributes value and reward potential to incoming stimuli, 
while the ACC is responsible for computing possible methods for attaining a goal, comparing 
these methods for their success potential, and evaluating outcome after an action has been 
implemented (Posner and DiGirolamo, 1998; Bush et al., 2000; Ochsner and Gross, 2005; Etkin 
et al., 2006; Rudebeck et al., 2008).  
 The OFC is activated by stimuli such as touch, taste, and smell, as well as more abstract 
reinforcers such as monetary gains and losses. It then integrates this information in order to 
create models of reward-based cause and effect (Kringelbach and Rolls, 2004; Rolls, 2004). 
Damage to the OFC impairs the learning and forgetting of associations between stimuli and 
rewards or losses. Thus, individuals with lesions to the OFC are unable to adjust their actions 
according to changes in the environment that influence goal attainment (Kringelbach and Rolls, 
2004; Rolls, 2004). Furthermore, individuals with damage to the OFC are less emotionally 
reactive to rewarding stimuli, have difficulty evaluating whether their choices have positive or 
negative outcomes, and demonstrate a decrease in self-motivated, goal-directed behavior 
(Bechara et al., 2000; Bechara, 2004).  
 The OFC is located in the ventromedial region of the frontal lobe. It can be divided into 
two distinct areas based on function and connectivity, namely the medial OFC (mOFC) and 
lateral OFC (lOFC). These areas are roughly equivalent to Brodmann areas 11 and 47, 
respectively. The mOFC has strong connections to the hippocampus, retrosplenial cortex, 
entorhinal cortex, and anterior thalamus (Morecraft et al., 1992; Carmichael and Price, 1995; 
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Cavada et al., 2000), and serves to monitor novel reward-based associations between stimuli, for 
example when a reinforcer is paired with a stimulus that was previously unrewarding (Mar et al., 
2011). The lOFC has strong connections with the amygdala, midline thalamus, DLPFC, and 
temporal pole (Barbas and De Olmos, 1990; Fuster, 2001), and is implicated in inhibiting 
behavior when a conditioned response no longer results in the expected reward (Mar et al., 
2011). As such, the mOFC and lOFC have differing roles in evaluating rewards and punishments 
(Kringelbach and Rolls, 2004). Specifically, stimuli associated with rewards are more 
prominently processed by the mOFC, whereas the lOFC is more strongly associated with 
processing stimuli associated with loss or punishment (Kringelbach and Rolls, 2004).  
 The role of the ACC within the RN is similar to the function it serves within the SN. 
Specifically, the ACC detects conflicts that may impede attainment of a goal, evaluates the 
potential rewards and losses associated with that conflict, initiates the most favorable solution by 
activating other brain networks (e.g., the CCN and motor system), and monitors the outcome of 
goal-directed actions (Bush et al., 2000). The ACC is associated with event-related potentials 
(ERPs) that follow negative or unintended outcomes of actions, including error-related negativity 
(ERN) and feedback-related negativity (FRN) (Miltner et al., 2003; Stemmer et al., 2004; Brázdil 
et al., 2005; Hogan et al., 2006; San Martín et al., 2010). Additionally, activation of the ACC 
occurs when a monetary loss is experienced on gambling tasks, and when an error is made on a 
decision-making task (Bush et al., 2002; Marsh et al., 2007).  
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 The ACC can be divided into a dorsal and a rostral area based on differences in 
connectivity and function. The dACC includes Brodmann area 32, while the Brodmann areas 
included in the rACC are the subgenual area 25 and pregenual area 33 (Starkstein et al., 2001; 
Haber, 2011; Menon, 2015). Functionally, the dACC is more involved in reward-based decision 
making, while the rACC is more involved with the experience and regulation of affective 
responses to feedback, for example when an individual experiences frustration associated with a 
loss (Taylor et al., 2006).  
 The dACC receives little sensory input, and instead has strong connections with areas 
that subsume executive control of cognition, emotion, and motor function, including the DLFC 
and premotor cortex (Mansouri et al., 2009). This allows it to fulfill its primary function of 
conflict monitoring and response selection (Ide et al., 2013). In the context of the RN, the dACC 
monitors for task-irrelevant stimuli that conflict with goal-directed action (Posner and 
DiGirolamo, 1998; Bush et al., 2000; Paus, 2001; Walton et al., 2003; Vogt, 2005).  Upon 
detection of information that signals a conflict, the dACC evaluates the potential rewards and 
losses associated with a conflict, and initiates the most favorable solution by activating other 
brain networks, such as the CCN and motor system. The dACC monitors for conflict in both 
internal states and external events. For example, the dACC is activated when an individual is 
exposed to competing stimuli that require cognitive inhibition of a preponderant response 
(Braver et al., 2001; Albert et al., 2012), such as during stop signal tasks, in which a prepotent 
 	  	  	  
	  	  	  	  
23 
response must be inhibited to instead allow response with a less intuitive response (Manza et al., 
2016).    
 The rACC has strong connections to structures that underlie emotional processes, such as 
the amygdala and hypothalamus. As such, the rACC is activated in the context of emotionally-
salient distracters (Whalen et al., 1998; Shin et al., 2001; Vuilleumier et al., 2001; Bishop et al., 
2004; Etkin et al., 2006). The rACC is activated during affect labeling (Kopelowicz et al., 1997; 
Burklund et al., 2007) and when individuals are required to distract themselves from fear-
inducing stimuli (Delgado et al., 2008). Furthermore, activation of the rACC inhibits amygdala 
activity, which allows regulation of emotional responses and serves to decrease interference of 
emotional distracters during goal-directed tasks (Etkin et al., 2006; Egner, 2008).  
 The OFC and ACC are connected to the AI, and these connections are of crucial 
importance to the functions they serve within the RN. The OFC receives multimodal sensory 
information from the AI, which the OFC then integrates to distinguish between reinforcing and 
aversive stimuli (Morecraft et al., 1992). The AI also signals information regarding unfavorable, 
interoceptive events, such as negative emotions and pain, to the ACC, thereby allowing the ACC 
to determine when an action fails to result in a desired outcome (Ibanez et al., 2010; Ichikawa et 
al., 2011; Couto et al., 2013). 
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The Role of the RN in Apathy 
 Apathy may be associated with an inability to perceive rewards and losses, resulting in a 
lack of motivation to initiate goal-direct action (Levy and Dubois, 2006; Schmidt et al., 2008). 
Indeed, several studies have implicated the RN in apathy. For example, SPECT studies 
examining apathy in individuals with AD have consistently found a decrease in blood perfusion 
to the OFC and ACC (Craig et al., 1996; Migneco et al., 2001; Benoit et al., 2002; Robert et al., 
2002; Rudebeck et al., 2006; Lanctôt et al., 2007). Furthermore, apathy is associated with 
disturbances in the dopaminergic mesolimbic and mesocortical pathways, which connect 
structures involved in reward processing. In rats, blockade of dopamine receptors inhibits the 
behavioral effects of rewarding and aversive stimuli (Chase, 2011). Primates with lesions in the 
dopaminergic mesolimbic pathway demonstrate apathetic behavior (Brown et al., 2012). In 
humans, depletion of dopamine in this pathway results in a decreased motivation to obtain a 
reward, while anticipation of a potential reward increases the firing rate of neurons within this 
pathway (Salamone et al., 2015). In individuals with dementia, apathy is associated with 
decreased dopamine uptake in the putamen and caudate nuclei, which are key subcortical 
structures associated with reward processing (Chase, 2011). Finally, clinical trials suggest the 
possible efficacy of dopaminergic agents for the treatment of apathy, which is attributed to an 
increase in dopamine within the mesolimbic pathway (Mann et al., 1995).  
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IV. INCENTIVE SALIENCE 
 Together, the different functions carried out by the SN and RN allow processing of 
incentive salience, which is required to determine which goals should be pursued and what the 
best strategy is to attain those goals (Delgado, 2007; Pool et al., 2016). Incentive salience 
involves the coupling of a desired incentive to a previously neutral stimulus, and as such, it 
describes the process by which an individual associates a future event with a positive valence 
and becomes motivated to obtain that specific goal. Incentive salience is synonymous to the 
action-inducing experience of “wanting”, which can be contrasted to the immediate, passive 
experience of hedonistic “liking” (Berridge et al., 2009; Zhang et al., 2009; Berridge and 
Kringelbach, 2015; Pool et al., 2016).  
 Incentive salience requires the integration of functions subsumed by the AI, OFC, and 
ACC. Specifically, within the context of incentive salience processing, the AI integrates salient 
sensory information, emotional experiences, and memories, and transfers this information to the 
OFC, where it is transformed into a conditioned stimulus with a motivational pull. The ACC then 
selects, initiates, and evaluates behavior that is most likely to result in attainment of the desired 
goal (Zhang et al., 2009; Pool et al., 2016).  
 Given that incentive salience requires participation of structures involved in both the SN 
and RN, it is possible that the processing of incentive salience is impaired in apathetic 
individuals, and underlies the decrease in motivation and goal-directed behavior in these 
individuals (Levy and Dubois, 2006; Schmidt et al., 2008). Indeed, abnormalities have been 
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identified in the connections between the SN and RN in individuals with apathy (Alexopoulos et 
al., 2013). For example, rsFC between the ACC and AI is increased in individuals with apathy, 
as is rsFC between the ACC and OFC (Alexopoulos et al., 2013). Another study found not only 
an association between apathy and poor sensitivity to reward, but also identified key involvement 
of the AI and prefrontal cortex, including the OFC, in reward insensitivity in apathetic 
individuals (Rochat et al., 2013). Finally, dopaminergic abnormalities within the mesolimbic 
network are associated with both apathy and the “wanting” aspect of incentive salience, as 
opposed to the more general “liking” aspect of the broader construct of reward (Berridge et al., 
2009; Berridge and Kringelbach, 2015).  
 Taken together, there is evidence of impaired incentive salience in apathy, as well as 
abnormalities within key structures underlying incentive salience. Thus, disturbances in the 
assignment of incentive salience, which can result from disruptions within both the salience and 
reward networks, may result in the emotional indifference and decreased goal-directed behavior 
that characterize apathy.  
 
V. CORTICAL THICKNESS 
The Cerebral Cortex 
 Changes of the cerebral cortex, such as thinning and volume loss, are common in older 
adults and may be associated with the high prevalence of apathy in late life. The cerebral cortex 
is comprised of gray matter, which consists mostly of neuronal cell bodies. The gray matter 
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forms a folded sheet at the surface of the cerebral hemispheres and cerebellum, of which the 
thickness varies between 1 and 4.5 millimeters. In addition, several gray matter structures are 
located below the cerebellum, including the thalamus, hypothalamus and basal ganglia, and in 
the brainstem, including the substantia nigra, red nucleus, olivary nucleus and cranial nerve 
nuclei.  
 Substantial decreases in gray matter volume and thickness occur with age (Jernigan et al., 
1991). These decreases occur secondary to morphological changes of neurons, such as a 
decreased neuronal size, loss of presynaptic terminals, and loss of the complexity of dendritic 
arborizations (Shipp, 2007). There are no specific age-related differences between left and right 
hemispheres changes. However, there appears to be a slightly faster decline in men than in 
women (Good et al., 2002).  Brain areas involved in salience and reward processing appear to be 
particularly susceptible to cortical changes in older adults. Specifically, the prefrontal, 
entorhinal, and temporal cortices undergo the most prominent changes with aging (Raz et al., 
1997). In contrast, the primary visual and primary somatosensory cortices appear to be more 
resilient to age-related processes (Raz et al., 1997). One study examined longitudinal changes in 
127 non-demented individuals aged 20 to 77 over five years (Raz et al., 2005), and found the 
greatest decrease in volume in the lateral prefrontal cortex. In this area, there was a change in 
volume of 0.91% yearly, corresponding with a total mean decrease of 7.83 cm3 over five years. 
In contrast, the smallest change was found in the primary visual cortex. This area showed a 
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0.05% decrease in volume per year, corresponding with a total mean change in volume of 1.51 
cm3 over five years.  
 
Measuring Cortical Thickness 
 Identification of changes of the gray matter is often labor intensive, and the highly folded 
nature of the cortex makes accurate estimation difficult. Automated methods have been 
developed, of which the two most widely used are measures of gray matter volume and cortical 
thickness (Ashburner and Friston, 2000; Fischl and Dale, 2000). Gray matter volume is measured 
using voxel-based morphometry, which is a procedure that requires division of gray matter into 
voxels, followed by a comparison of the concentration of voxels between two brain areas 
(Ashburner and Friston, 2000). This procedure involves spatial normalization of neuroimaging 
data, smoothing of gray-matter segments, and application of voxel-wise parametric statistical 
tests. Analysis of cortical thickness follows a similar method, including spatial normalization of 
neuroimaging data and smoothing of gray-matter segments. However, the final step involves 
estimating the distance between white matter and the pial surface at different regions in the brain.  
 The extent to which there is a correlation between measures of cortical volume and 
thickness is unclear. However, cortical thickness is less susceptible to bias caused by gray matter 
folding, and may therefore be considered a more valid method for measuring gray matter 
changes in late-life (Hutton et al., 2009; Winkler et al., 2010; Pereira et al., 2012). 
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VI. AIMS AND HYPOTHESES 
 Despite the wide-range of adversities associated with apathy in late-life depression, 
apathy is often left undiagnosed and untreated in these individuals (Chase, 2011). Apathy and 
late-life depression have distinct clinical characteristics and separable neuroanatomical 
abnormalities that indicate that these disorders are dissociable entities that require separate 
approaches to treatment (Marin, 1991; Marin et al., 1993; Levy et al., 1998; Reyes et al., 2009; 
Njomboro and Deb, 2012; Pardini et al., 2016). Developing a better understanding of the 
syndrome of apathy and elucidating its specific etiological abnormalities are crucial steps toward 
identifying more effective treatments for the disturbances associated with apathy in older 
depressed adults.  
 Given evidence for the involvement of fronto-subcortical structures in the apathy of late-
life depression, and especially for those areas involved in the processing of incentive salience, 
the aim of the current study was to examine the association between apathy and gray matter 
abnormalities in the SN and RN. Specifically, we examined cortical thickness of the right AI, 
ACC and OFC in older depressed adults with and without apathy. In addition, we examined the 
association between these areas and persistence of apathy symptoms following 12 weeks of 
antidepressant treatment with the SSRI escitalopram.  
 We focused on cortical thickness of the right hemisphere for various reasons. First, 
abnormalities (e.g., focal lesions) in the right hemisphere are more commonly associated with 
apathy than abnormalities in the left hemisphere. Second, there is hemispheric lateralization of 
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the SN, such that the right AI is more strongly involved in salience processing than the left AI. 
Finally, VENs connecting structures within the SN occur with more abundance in the right than 
the left hemisphere.   
 Relative to non-psychiatric comparison participants, we expected there to be a high rate 
of apathy among individuals with late-life depression. We further hypothesized that the cortical 
thickness within key areas of the SN and RN (i.e., right AI, OFC, and ACC) would be less in 
apathetic older, depressed adults than in their non-apathetic counterparts, and that decreased 
cortical thickness within these areas would predict non-response of apathy symptoms to 12-
weeks of escitalopram treatment.  
 We also performed exploratory analyses examining the cognitive profile of apathetic 
individuals with late-life depression in order to further characterize apathy in late-life depression. 
Compared to non-apathetic individuals, we expected that older, depressed adults with apathy 
would show impairment in executive functions, including cognitive inhibition, set shifting, and 
executive control aspects of memory.   
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METHODS 
I. PARTICIPANTS 
 Participants were depressed or psychiatrically healthy older adults (>60 years) without 
dementia or mild cognitive impairment (MCI) who were recruited through radio and print 
advertisement in community media outlets. The patient group consisted of 50 older adults with a 
DSM-IV diagnosis of major depressive disorder without psychotic features. Diagnostic 
evaluation was conducted by clinical psychologists using the Structured Clinical Interview for 
DSM-IV Axis I, clinical trial version (SCID-CT) (First et al., 1995), and by study psychiatrists 
through clinical interview. Trained research assistants assessed eligibility using the 24-item 
Hamilton Depression Rating Scale (HDRS) (Hamilton, 1960; Hamilton, 1980), and the Mini-
Mental State Examination (MMSE) (Folstein et al., 1975). Depressed individuals were included 
in the study if they met DSM-IV criteria for major depressive disorder, scored 18 or higher on 
the HDRS (i.e., moderate depression), and scored 25 or higher on the MMSE (i.e., cognitively 
intact). Depressed patients were excluded if they met any of the following criteria: 
• High suicide risk with plan or intent, as determined by a study psychiatrist through 
clinical interview. 
• Past or present axis I psychiatric disorder or substance abuse. Patients with a history of 
depression were not excluded. Given the high comorbidity between late-life depression 
and generalized anxiety disorder (GAD), patients with a history of GAD were also not 
excluded. 
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• Acute or severe medical illness within the three months preceding entry to the study. 
• Current involvement in psychotherapy, given that this would bias outcome measures of 
response to pharmacological treatment. 
 The comparison group consisted of 40 non-demented participants without past or present 
psychiatric disorder or treatment, without acute or severe medical illness within the past three 
months preceding entry to the study, and with an MMSE score of 25 or higher.  
 Patients and controls were screened by phone, prior to being invited for an in-person visit 
to further assess eligibility. Participants were provided with small monetary compensations, as 
well as 12-weeks of free treatment with escitalopram. The Institutional Review Boards of the 
Weill Cornell Medical College and Rockland Psychiatric Center/Nathan S. Kline Institute for 
Psychiatric Research approved all procedures. All participants received a complete description of 
the study and signed written informed consent statements prior to participation. 
 
II. ASSESSMENT 
•  Depression Severity: The 24-item HDRS was used to quantify depression severity. The 
HDRS is a clinician-rated, interview-based scale that evaluates a variety of symptoms 
commonly associated with depression during the week prior to the assessment, such as low 
mood, feelings of guilt, suicidal ideation, insomnia, reduced appetite, agitation/retardation, 
anxiety, and somatic complaints. The HDRS consists of 24 items that are scored on either a 
three or five point Likert scale. A total score of 0-7 is considered normal, while 18 or 
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higher indicates moderate depression, and a score of 30 or more suggests severe 
depression. The HDRS is considered by many to be the “gold standard” for assessing 
depression severity in clinical trials, and is the most commonly used measure of depression 
in clinical practice (Williams, 2001; Demyttenaere et al., 2003).  
• Diagnostic Evaluation: The SCID-CT is a semi-structured diagnostic interview used to 
determine DSM-IV Axis I disorders. It is designed to carefully assess inclusion/exclusion 
criteria for clinical trials. It provides customizable indication-specific configurations of the 
modules. The version used for the current study was designed to provide full evaluation of 
mood symptoms, and screening of other DSM diagnoses.  
• Apathy Severity: The clinician-rated version of the Apathy Evaluation Scale (AES) 
(Marin et al., 1991) was used to quantify symptoms of apathy. The AES is an 18-item scale 
that evaluates three dimensions of apathy within one month prior to the assessment, 
including behavioral apathy (e.g., “I get things done every day”), cognitive apathy (e.g., “I 
am interested in learning new things”), and emotional apathy (e.g., “When something good 
happens, I get excited”). The measure uses a four-point Likert scale that requires 
individuals to rate each item as "not at all,” "slightly,” "somewhat,” or "a lot.” A score of 
36.5 or higher is considered an indication of clinically significant apathy (Clarke et al., 
2007). The AES is among the most widely used measures of apathy severity in both 
research and clinical practice (Clarke et al., 2010). It includes seven items that lack 
correlation with the HDRS, and as such, the AES is able to reliably differentiate between 
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apathy symptoms and depression (Marin et al., 1991). In addition, reliability and validity of 
the AES has been demonstrated in adults with major depressive disorder through 
examination of interrater reliability, and convergent, divergent, and internal validity (Marin 
et al., 1991). Although informant-rated and self-report versions of the AES exist, this study 
utilized the clinician-rated version, given that older depressed adults with apathy may 
underreport psychiatric symptoms (Derouesné et al., 1999; Mograbi and Morris, 2014), and 
informants were not always available.  
• Cognitive Functioning 
o Mini-Mental Status Examination (MMSE): The MMSE is brief screening measure 
that assesses cognitive impairment. Items examine a broad range of cognitive 
functions, including attention, working memory, orientation, language, memory, and 
visuomotor functioning. The maximum score of 30 can be obtained on this measure. 
A score lower than 25 suggests cognitive impairment. Scores ranging from 19 to 24 
are considered indicative of mild cognitive impairment, while scores in the 10 to 18 
point range are considered to be indicative of moderate cognitive impairment, and 
scores below 10 are considered indicative of severe cognitive impairment.   
o Hopkins Verbal Learning Test-revised version (HVLT): This measure evaluates 
learning and memory of rote information (i.e., a word list) (Benedict et al., 1998). 
The examiner reads a list of 12 nouns to the examinee, after which the examinee is 
asked to recall as many words as possible. This is repeated three times. Following a 
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20- to 25-minute delay, the individual is asked to again recall as many words as 
possible. A recognition trial is also administered, during which the examiner reads 
24 words (12 target items and 12 distractor words), and the individual must indicate 
whether a word was on the original list. The HVLT allows the examination of 
several cognitive processes involved in learning, recall, recognition, and the 
executive control processes involved in memory (e.g., retrieval and source 
monitoring). As such, the HVLT taxes several brain areas, most notably in the 
frontal and temporal lobes.  
o Stroop Color and Word Test: The Stroop color and Word Test (Stroop, 1935; Golden 
and Freshwater, 1978) was used as a measure of processing speed and cognitive 
inhibition. The measure consists of three trials. The first two trials evaluate 
processing speed, and require an individual to read the names of colors printed in 
black ink (“word reading”), and to name colors of rows of X’s printed in either 
green, red, or blue (“color naming”). The third trial consists of the words from the 
first trial, printed in mismatched colors from the second trial ("color/word"). An 
individual is required to name the color of the ink in which each item is printed, 
while ignoring the word that is printed. Because the meaning of the written word is a 
more salient aspect of each item than the color of the ink, examinees are required to 
inhibit the tendency to read the word in order to fulfill the tasks requirement. The 
score for each trial consists of the number of correct responses within a 45 second 
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period, such that higher scores represent stronger performance. This results in a 
score for all three trials, from which a fourth score is derived that quantifies an 
individual’s ability to inhibit salient responses. The interference score is calculated 
with the following formula: 
cw' = cw – 
!∗!!!! 
 In this equation, “cw’” represents the interfence score, “cw” is the score obtained on 
the color/word trial, “w” represents the score on the word trial, and “c” represents 
the score on the color trial.  
  Different trials of the Stroop Color and Word Test are associated with 
abnormalities in different brain areas. Left hemisphere or diffuse injuries attenuate 
all scores, while reduced performance on the color-naming and color/word trials are 
associated with right-hemisphere injuries (Golden and Freshwater, 1978), and 
abnormalities in the frontal lobe are associated with impaired cognitive inhibition 
(Perret, 1974; Golden and Freshwater, 1978; Vendrell et al., 1995). Specifically, 
cognitive inhibition predominantly taxes two areas of the brain, including the ACC 
and the DLPFC (Milham et al., 2003).  
o Trail Making Test (TMT): The TMT (Army, 1944) is a measure of psychomotor 
speed, scanning, and rapid set shifting. The measure consists of two trials. On the 
first trial (trial “A”) individuals are required to connect 25 numbers scattered on a 
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page in sequential order. On the second trial (trial “B”), individuals are required to 
connect 25 numbers and letters in sequential order, alternating between numbers and 
letters. Two scores are derived consisting of the time taken to complete a trial. The 
score for trial A is considered a measure of psychomotor speed, while the score for 
trial B is reflective of set shifting ability. The neural networks underlying set shifting 
ability are complex, and involve both cortical and subcortical areas (Kramer et al., 
2007; Mukhopadhyay et al., 2007). Nonetheless, set shifting is considered 
predominantly an aspect of cognitive control, which is mediated by the ACC and 
DLPFC (Nakahara et al., 2002; Ravizza and Ciranni, 2002; Brass et al., 2005).  
o Wisconsin Card Sorting Test-64 item computer-version (WCST): The WCST is a 
measure of conceptualization, cognitive flexibility, and novel problem solving 
(Grant and Berg, 1948). Individuals are presented with four key cards on which 
different shapes are printed. Each card differs in the number of shapes, the type of 
the shapes, and the color of the shapes. The individual is then presented with 64 
cards that also contain shapes differing in type, color, and number. Individuals are 
asked to match each card with a key card, and receive feedback on whether or not a 
match is correct or incorrect, requiring the individual to deduce matching rules from 
the feedback provided. The tasks allows calculation of a number of different scores, 
including the number of categories completed, the number of perseverative errors 
made, and the number of times an individual deviates from a category after several 
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correct responses (“failure to maintain set”). While this measures requires 
integration of several brain functions, it includes a prominent component of 
cognitive flexibility, which is subsumed by the ACC and DLPFC (Kleinman et al., 
2013).  
• Cortical Thickness: Cortical thickness is a brain morphometric measure used to quantify 
the thickness of cerebral cortex. It is measured by determining the distance between 
white matter and pial surfaces using semi-automated methods (see MRI procedures).   
 
III. TREATMENT 
 Depressed participants entering the study underwent a two-week single-blind placebo 
lead-in/wash-out phase. Participants who continued to meet eligibility criteria after the first two 
weeks were treated with an SSRI (i.e., escitalopram) at a daily target dose of 10mg for 12 weeks, 
as recommended by the FDA. Depressed participants received weekly assessments throughout 
the treatment trial. These assessments consisted of a brief meeting with a research psychiatrist, 
and administration of rating scales by trained research assistants. Assessments focused on the 
evaluation of psychiatric symptoms and side effects; participants did not receive psychotherapy.  
 
IV. MRI PROCEDURES 
• Image Acquisition: Scans were acquired on a Siemens 1.5T Vision MR system 
(Erlangen, Germany) at Nathan Kline Institute’s Center for Advanced Brain Imaging. 
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Control participants received a scan following their baseline evaluation. Depressed 
participants were scanned at the end of a 2-week single-blind placebo lead-in/drug 
washout phase. Participants received a magnetization prepared rapidly acquired gradient 
echo (MPRAGE) T1-weighted scan (TR =11.6 ms, TE = 4.9 ms, TI = 1017.6 ms, matrix 
= 256 × 256, FOV = 320 mm, NEX = 1, slice thickness = 1.25 mm, 172 slices, no gap), 
as well as a turbo dual spin echo scan (TR = 5000 ms, TE = 22/90 ms, matrix = 256 × 
256, FOV = 240 mm, slice thickness = 5, 26 slices, no gap). 
• Image Processing: MPRAGE images for each participant were processed using an 
automated segmentation method (Fischl and Dale, 2000; Fischl, 2012), which constructs 
boundaries between white matter and pial surface. This segmentation process consists of 
the following serial processing steps. First, motion corrections and intensity 
normalizations are applied. This is followed by an affine registration to MNI305 space 
(Collins et al., 1994). Next, skull stripping is performed, after which white matter, gray 
matter, and pial surface are identified based on intensity and neighbor constraints. Error 
analyses and corrections are applied throughout the segmentation process. Cortical 
thickness is then measured by calculating the distance between white matter and pial 
surface. Finally, an automated labeling system is used to identify different regions of 
interest (ROIs). For this final step, we used a gyral-based atlas (Desikan et al., 
2006). This atlas, referred to as the Desikan-Killiany atlas, was developed based on 
gyral morphology, and consists of 34 cortical areas (Figure 8). The atlas was developed 
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using MRI scans of 40 subjects who varied widely in age and clinical status, in order to 
account for variability in studies of aging and dementia. ROIs were manually delineated 
by tracing from the depth of one sulcus to another, thereby including both gyri and 
banks of adjacent sulci. The final automated cortical atlas was generated by using a 
probabilistic registration procedure across all 40 manually labeled brains. The current 
study utilized only right hemisphere structures, given evidence of right-hemisphere 
dominant involvement in apathy and salience processing. Because the Desikan-Killiany 
atlas is based on morphologically distinct regions, whereas the delineation of structures 
associated with the SN and RN is based on functional and connective distinctions, not 
all ROIs corresponded exactly with those available in the atlas. Thus, ROIs were chosen 
that had the greatest topographical overlap. For the AI, the atlas ROI labeled “insula” 
was used, which includes both the AI and PI. For the dACC, the atlas ROI labeled 
“caudal anterior cingulate” (cACC) was selected. This area includes the dACC 
(Brodmann area 32), as well as Brodmann area 24, which is a small section of the ACC 
that lies ventral to the dACC. For the rACC, an atlas ROI was used that is equivalent in 
both name and topography. This area encompasses the subgenual Brodmann area 25 and 
the pregenual Broadmann are 33. Atlas ROIs equivalent in both name and topography 
were also used for the mOFC and lOFC. These areas roughly correspond to Brodmann 
areas 11 and 47, respectively.   
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V. DATA ANALYSIS 
• Statistical analyses were performed with SPSS 24.0 (Corp, 2013), G*Power (Faul and 
Erdfelder, 1992), and STATA (Stata, 2009).  
• Data Cleaning: Missing data analyses were conducted for all variables included in the 
study. Adjustments to the data set were made as needed. A score was considered an 
outlier if it differed from either Q1 or Q3 by more than double the interquartile range. 
After visual inspection of any identified outlier, adjustments to the data set were made if 
a score was considered erroneous.  
• Assumptions: The data was examined to ensure that all requirements were met before 
conducting any statistical analyses.  
o Normality was determined with the Shapiro-Wilk test. In addition, Q-Q plots were 
visually inspected. 
o Equality of variances was determined using Levene’s test. 
o Independence of observations was determined using the Durbin-Watson test. The 
absence of a correlation between residuals was assumed if this test resulted in a 
value of approximately two.  
o To test for linearity, partial regression plots for each independent and dependent 
variable in a model were inspected.   
o Homoscedasticity was assessed by visual inspection of scatterplots of studentized 
residuals and unstandardized predicted values.  
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o Tolerance and VIF values were used to inspect multicollinearity. If a variable had a 
tolerance value of more then 0.7 and a corresponding VIF of 10 or greater, 
collinearity was assumed. 
o Histograms and P-P Plots were used to examine normal distribution of residuals. 
• Demographics: T-tests and Fisher’s exact tests were used to compare the demographic 
and clinical characteristics of controls and depressed older adults. For the t-tests, 
student’s t-tests were used if Levene’s tests indicated equal variances. In all other 
instances, Welch’s test was used. Demographic and clinical characteristics were also 
contrasted between controls, depressed individuals with apathy, and depressed 
individuals without apathy. For these analyses, one-way ANOVAs were used in 
combination with Tukey’s HSD post hoc tests if Levene’s tests indicated equal 
variances. In all other instances, Welch’s ANOVA and Games-Howell post hoc tests 
were used.  
• Treatment response: Change in apathy severity following antidepressant treatment was 
calculated by subtracting week 12 AES scores from baseline AES scores. Thus, higher 
AES change scores indicated a more favorable response to antidepressant treatment. T-
tests and Welch’s tests were used to examine change in symptoms of apathy and 
depression following 12 weeks of antidepressant treatment. Student’s t-tests were used if 
Levene’s tests indicated equal variances. In all other instances, Welch’s test was used. 
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• Regressions: Hierarchical linear regressions were conducted to examine the relationship 
between specific ROIs and AES score within the depressed group of participants. 
Covariates were entered at level one of each model to control for their effect on apathy 
severity (see Covariates).  Cortical thickness of ROIs within the SN and RN was 
included in the second level of the analyses. The third level included interaction terms, 
which were calculated by multiplying the thickness of different ROIs. All analyses were 
conducted at an alpha level of .05. 
• Covariates: Covariates were chosen based on their expected mediating properties 
between independent and dependent variables. Given the high correlation between 
depression severity and apathy, and the possible involvement of ROIs within the SN and 
RN in the clinical expression of both apathy and depression, HDRS scores were 
included at level one of hierarchical regressions examining associations between ROIs 
and AES scores. Modified HDRS scores were calculated by omitting items that assess 
apathy symptomatology in order to ensure that relevant variance was not removed from 
the model, including diminished work/interests, psychomotor retardation, anergia, and 
lack of insight (Marin et al., 1993; Yuen et al., 2014). Because individuals with higher 
scores on the AES and HDRS at baseline have more opportunity to decrease their scores 
upon receiving treatment, regression models examining change in AES score over time 
included both baseline AES scores and modified baseline HDRS scores. Mean cortical 
thickness was also included at level one of regression models examining cortical 
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thickness of ROIs, in order to control for inherent individual variability. Other 
covariates, including age, gender, and education, were also considered. However, given 
weak evidence of mediating properties for these variables, as well as non-significant 
correlations between these covariates and other variables in this study’s models, these 
covariates were not included.   
• Exploratory analyses: For the exploratory analyses, hierarchical linear regressions were 
conducted to examine the relationship between cognitive functioning and AES score 
within the depressed group of participants. A modified HDRS score, as previously 
described, was included in the first level of each regression model to control for the 
influence of this variable. Performance on different measures of cognitive functioning 
was included in the second level of the analysis. Hierarchical linear regressions were 
also conducted to examine the relationship between cognitive functioning and change in 
AES score following 12 weeks of antidepressant treatment. Given the high correlation 
between baseline apathy and depression, and change in apathy and depression, variables 
to control for these effects were included in the model at levels one and two. 
Performance on different measures of cognitive functioning was included in the third 
level of the analysis. All analyses were conducted at an alpha level of .05. 
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RESULTS  
I. MISSING DATA 
 Among the sample of 50 older depressed adults, 92% had baseline AES data (n=46; 
M=36.7, SD=10.36), and 64% had week 12 AES data (n=32; M=27.63, SD=7.81). Twenty-nine 
participants had both baseline and week 12 AES data (Baseline AES: M=35.55, SD=11.44; 
Week 12 AES: M=27.07, SD=7.95). Three participants did not have baseline AES data. There 
was no significant difference between the week 12 AES scores of participants who did and did 
not have baseline AES data (t(4.4)=-2.3, p=.07). Seventeen participants did not have week 12 
AES data. There was no significant difference between the baseline AES score of participants 
who did and did not have week 12 AES data (t(42.2)=-1.1, p=.29). One participant had neither 
baseline nor week 12 AES data. This participant was excluded from further analyses, resulting in 
a total sample size of 49 individuals with late-life depression.  
 Among the remaining 49 participants, all had baseline HDRS data (M=22.2, SD=3.74). 
Of these individuals, 69.4% also had week 12 HDRS data (n=34; M=6.91, SD=5.47). There was 
no difference in baseline HDRS score between participants who did and did not have week 12 
data (t(23.3)=-1.2, p=.25). Baseline scores for individual items on the HDRS were available for 
all participants, and therefore adjusted baseline HDRS scores, which excluded apathy items, 
could be calculated for all participants. Seven participants with week 12 HDRS data did not have 
scores available for individual items on the HDRS. Therefore, adjusted HDRS scores could be 
calculated for 27 participants (MD=5.26, SD=5.3). There was no difference between the week 12 
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HDRS scores of those who did and did not have data available for individual items (t(32)=.43, 
p=.67).    
 MRI data was complete for all 49 participants.  
 
II. OUTLIER ANALYSES 
 Among the complete sample of 49 older depressed adults, none of the participants had 
extreme scores on the AES at either baseline or week 12. Two participants had outlying scores 
on the HDRS at baseline (i.e., 33 and 34). However, when compared only to individuals with 
apathy at baseline, these scores were not considered outliers. Therefore, these participants were 
not excluded from further analyses. There were no outlying scores on the HDRS at week 12. One 
participant had an extremely low value on lOFC thickness (i.e., 1.61). Because this score is not 
outside the range of what is considered typical for cortical thickness (Fischl and Dale 2000), this 
individual was not removed from further analysis. No outliers were identified for the cortical 
thickness of other ROIs. There were also no outliers in mean cortical thickness. Among cognitive 
measures, one individual had an extremely high number of false positive errors on the HVLT at 
baseline (i.e., five), and this participant was therefore excluded from the analysis. One individual 
had an extreme score on the TMTB at baseline (i.e., 300). This score indicates that this 
individual was unable to complete this task within the maximum allowed time, and this 
participant was therefore excluded from the analysis. No outliers were identified on any other 
cognitive measure. 
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 Of the twenty-five older depressed adults who did not have clinically significant apathy 
at baseline, one individual had an extreme score on the TMTA at week 12 (i.e., 87). Although 
this score is indicative of impairment, it is not uncommon in clinical practice (Tombaugh 2004). 
In addition, when compared to the complete sample of 49 participants, this score did not 
constitute and extreme value. This individual was therefore not excluded from further analysis. 
There were no other outliers on measures of symptom severity, cortical thickness, or cognitive 
ability within the sample of non-apathetic, depressed older adults. 
 Other than the aforementioned extreme score of five false positive errors on the HVLT at 
baseline, there were no other outliers on measures of symptom severity, cortical thickness, or 
cognitive ability within the sample of depressed older adults who were apathetic at baseline.  
 
III. DEMOGRAPHIC AND CLINICAL CHARACTERISTICS  
 The entire sample included in the analyses consisted of 89 older adults. Of these, 49 
participants met inclusion criteria for depression, and 40 participants were non-depressed 
controls (Table 1). There were no significant differences in age, gender, education, and MMSE 
between depressed and control participants. At baseline, depressed participants had significantly 
higher HDRS and AES scores than their non-depressed counterparts. There was no longer a 
significant difference between the AES scores of depressed participants and controls after 12 
weeks of escitalopram treatment. In contrast, depressed participants continued to have 
significantly higher HDRS scores than controls after 12 weeks of escitalopram treatment. 
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 Within the group of depressed older adults, 21 had a score above 36.5 on the AES at 
baseline, indicating clinically significant apathy (Table 2). There were no significant differences 
in age, gender, education, and MMSE between controls, depressed individuals without apathy at 
baseline, and depressed individuals with apathy at baseline. At baseline, AES scores differed 
significantly between controls, depressed individuals without apathy at baseline, and depressed 
individuals with apathy. Baseline scores on the HDRS were significantly different between 
controls and the samples of both apathetic and non-apathetic depressed participants, but not 
between depressed individuals without apathy at baseline and depressed individuals with apathy. 
HDRS scores at week 12 were significantly different only between controls and depressed 
individuals without apathy at baseline.  
 
IV. ANTIDEPRESSANT TREATMENT RESPONSE  
 Among the complete sample of 49 depressed older adults, depressive symptoms were 
significantly more responsive to antidepressant treatment than symptoms of apathy (t(28)=-4.53, 
p=<.01). Participants improved an average of 15 points (SD=7.35) on the HDRS after 12 weeks 
of antidepressant treatment, which represented a 68% decrease from baseline. In contrast, the 
mean change in AES score following 12 weeks of antidepressant treatment was 8.48 points 
(SD=10.14), which represented a 23% decrease from baseline.  
 Following 12 weeks of escitalopram treatment, 55.6% of depressed older adults (n=25) 
remitted from depression. There was no difference between the remission rates of those with and 
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without apathy at baseline (p=.35; Fisher’s exact test). Participants with apathy at baseline 
experienced an average improvement of 15.77 points (SD=9.9) on the HDRS, which represented 
a 68% decrease from baseline. Those without apathy at baseline improved an average of 14.83 
points (SD=4.58), which also represented a 68% decrease from baseline. 
 Within the sample of participants who were apathetic at baseline, 72.7% (n=8) no longer 
met apathy criteria after 12 weeks of treatment with escitalopram. The average improvement in 
AES score amongst those who were apathetic at baseline was 16.18 points (SD=12.42), which is 
a 36% improvement from baseline. There was no significant difference between change in 
apathetic and depressive symptoms following treatment in this sample (t(10)=.54, p=.6).   
 
V. STRUCTURAL ABNORMALITIES WITHIN THE SN  
Baseline 
 A three-level hierarchical linear regression was constructed to examine the association 
between cortical thickness within ROIs of the SN and apathy in older depressed adults (Table 3; 
Graph 1). Baseline AES score was included as the dependent variable. Two covariates were 
added at level one of the model to control for mediating effect between cortical thickness of 
ROIs and apathy severity, including mean cortical thickness and a modified baseline HDRS 
score that excluded items previously shown to be sensitive to apathy. Cortical thickness of ROIs 
within the SN (insula and cACC) was entered at level two of the regression. Finally, an 
interaction term between the insula and the cACC was added at level three. However, 
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examination of assumptions revealed significant multicollineraty between ROIs and this 
interaction term, which was not resolved by centering the variables. As such, the interaction term 
was omitted from the final model.  
 All remaining assumptions were met. There was linearity, as assessed by partial 
regression plots and a plot of studentized residuals against the predicted values. There was 
independence of residuals, as assessed by a Durbin-Watson statistic of 2.07. Visual inspection of 
a plot of studentized residuals and unstandardized predicted values revealed adequate 
homoscedasticity. There were no studentized deleted residuals greater than ±3 standard 
deviations from the mean. The assumption of normality of residuals was met, as assessed by 
inspection of P-P Plots.  
 At level one of the hierarchical linear regression, depression severity was a statistically 
significant predictor of baseline AES score, whereas mean cortical thickness was not. 
Introducing the ROIs into the model at level two resulted in a non-significant increase in 
explained variance of 2% (F(2,41)=.37, p=.69). Within this final model, only the modified 
HDRS score significantly predicted baseline apathy severity on the AES. 
 
Week 12  
 A three-level hierarchical linear regression was conducted to examine whether cortical 
thickness of ROIs within the SN were predictive of apathy severity following 12 weeks of 
antidepressant treatment with escitalopram (Table 4; Graph 2). In this model, week 12 AES score 
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was included as the dependent variable. Mean cortical thickness and a modified HDRS score at 
week 12 that excluded items assessing symptoms of apathy were added at level one of the model 
to control for their mediating effect on the dependent variable. Cortical thickness of ROIs within 
the SN (insula and cACC) was entered at level two of the regression. An interaction term 
between the insula and the cACC was added at level three. However, this again resulted in 
significant multicollinearity, and as such, the interaction was removed from the final model. 
 All remaining assumptions were met. There was linearity, as assessed by partial 
regression plots and a plot of studentized residuals against the predicted values. There was 
independence of residuals, as assessed by a Durbin-Watson statistic of 2.57. There was 
homoscedasticity, as assessed by visual inspection of a plot of studentized residuals and 
unstandardized predicted values. There were no studentized deleted residuals greater than ±3 
standard deviations from the mean. The assumption of normality of residuals was met, as 
assessed by inspection of P-P Plots. 
 At level one of the hierarchical linear regression, modified week 12 HDRS score was 
significantly predictive of week 12 AES score, whereas mean cortical thickness was not. Adding 
ROIs at level two of the model resulted in an insignificant increase in explained variance of 13% 
(F(2,21)=3.22, p=.06). Within this model, modified week 12 HDRS score remained significantly 
predictive of week 12 AES score. In addition, insular thickness also significantly predicted week 
12 AES score; specifically, insular thickness was decreased in individuals with higher AES 
scores at week 12 (B=-17.66, SE=6.97).  
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Change in Apathy Severity  
 A three-level hierarchical linear regression was conducted to examine the extent to which 
cortical thickness of ROIs within the SN could predict change in apathy severity following 
antidepressant treatment (Table 5; Graph 3). In this model, change in AES score between 
baseline and week 12 was included as the dependent variable. Given the association between 
symptom severity at baseline and symptom improvement following antidepressant treatment, 
baseline AES score and modified baseline HDRS score were both included at level one of the 
model. In addition, mean cortical thickness was included at this level of the model to account for 
its mediating effect between ROI thickness and apathy severity. At level two, ROIs within the 
SN (i.e., insula and cACC) were added to the model. A third level consisting of an interaction 
term between the insula and the cACC was omitted, secondary to multicollinearity. 
 All remaining assumptions were met. Partial regression plots and a plot of studentized 
residuals against the predicted values were examined to ensure linearity. A Durbin-Watson 
statistic of 2.18 provided indication of independence between residuals. There was 
homoscedasticity, as assessed by visual inspection of a plot of studentized residuals and 
unstandardized predicted values. There were no studentized deleted residuals greater than ±3 
standard deviations from the mean. The assumption of normality of residuals was met, as 
assessed by inspection of P-P Plots. 
 At level one of the model, modified baseline HDRS score and baseline AES score were 
both significantly predictive of improvement in apathy following antidepressant treatment with 
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escitalopram. Adding cortical thickness of ROIs at level two of the model resulted in a 
statistically significant increase in variance explained of 8.9% (F(2,23)=4.74, p=.02). At level 
two of the model, modified baseline HDRS score and baseline AES score continued to be 
predictive of change in AES score. Within the SN, thickness of the insula was also significantly 
predictive of improvement in AES score; specifically, individuals with greater insular thickness 
demonstrated a greater decrease in AES score following antidepressant treatment (B=20.12, 
SE=6.63).    
 
VI. STRUCTURAL ABNORMALITIES WITHIN THE RN   
Baseline  
 A three-level hierarchical linear regression was conducted to examine the extent to which 
cortical thickness within ROIs of the RN predicted baseline apathy severity (Table 6; Graph 4). 
In this model, baseline AES score was included as the dependent variable. Modified baseline 
HDRS score and mean cortical thickness were entered at level one of the model to account for 
their mediating effect between cortical thickness of the ROIs and AES score. At level two, 
cortical thickness of ROIs within the RN (rACC, cACC, lOFC and mOFC) was entered. 
Interaction terms between orbitofrontal areas and areas within the ACC were added at level 
three. However, inclusion of these interaction terms resulted in significant multicollinearity, and 
as such, the interactions were removed from the final model. 
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 All remaining assumptions were met. There was linearity, as assessed by partial 
regression plots and a plot of studentized residuals against the predicted values. There was 
independence of residuals, as assessed by a Durbin-Watson statistic of 2.1. There was 
homoscedasticity, as assessed by visual inspection of a plot of studentized residuals and 
unstandardized predicted values. There were no studentized deleted residuals greater than ±3 
standard deviations. The assumption of normality of residuals was met, as assessed by inspection 
of P-P Plots. 
 Level one of the hierarchical regression revealed that the modified baseline HDRS score 
significantly predicted baseline AES score, whereas mean cortical thickness did not. A 10% 
change in explained variance occurred after introducing the ROIs into the model, but this change 
was not significant (F(4,39)=1.3, p=.29). Within this model, modified baseline HDRS score was 
predictive of baseline apathy severity. In addition, thickness of the rACC significantly predicted 
baseline apathy severity; specifically, rACC thickness was decreased in individuals with higher 
AES scores at baseline (B=-14.48, SE=6.56).  
 
Week 12 
 A three-level hierarchical linear regression was conducted to examine the whether 
cortical thickness within ROIs of the RN predicted apathy following 12 weeks of antidepressant 
treatment (Table 7; Graph 5). In this model, week 12 AES score was included as the dependent 
variable. A modified HDRS score at week 12 that excluded items assessing apathy was entered 
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to the regression as a covariate at level one. Mean cortical thickness was also included in the 
model as a covariate at level one. At level two, cortical thickness of ROIs within the RN (rACC, 
cACC, lOFC and mOFC) was entered. Interaction terms between orbitofrontal areas and areas 
within the ACC were added at level three of the model. However, these again resulted in 
significant multicollinearity, and as such, the interactions were removed from the final model. 
 All remaining assumptions were met. There was linearity, as assessed by partial 
regression plots and a plot of studentized residuals against the predicted values. There was 
independence of residuals, as assessed by a Durbin-Watson statistic of 2.54. There was 
homoscedasticity, as assessed by visual inspection of a plot of studentized residuals and 
unstandardized predicted values. There were no studentized deleted residuals greater than ±3 
standard deviations. The assumption of normality of residuals was met, as assessed by inspection 
of P-P Plots. 
 Level one of the hierarchical regression revealed that the modified week 12 HDRS score 
significantly predicted week 12 AES score, whereas mean cortical thickness did not. A 2%, non-
significant change in explained variance occurred after introducing the ROIs into the model 
(F(4,19)=.21, p=.93). In this model, only the modified week 12 HDRS score significantly 
predicted week 12 AES score.  
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Change in Apathy Severity 
 A three-level hierarchical linear regression was conducted to examine the association 
between cortical thickness within ROIs of the RN and change in apathy following 12 weeks of 
antidepressant treatment (Table 8; Graph 6). In this model, a variable reflecting the difference 
between AES score at baseline and week 12 was included as the dependent variable. Given the 
association between symptom severity at baseline and symptom improvement following 
antidepressant treatment, baseline AES score and a modified baseline HDRS score were both 
included at level one of the model. In addition, mean cortical thickness was included at this level 
of the model to account for its mediating effect between ROI thickness and apathy severity. 
Cortical thickness of ROIs within the RN (rACC, cACC, lOFC, and mOFC) was entered at level 
three of the regression. Interaction terms between orbitofrontal areas and areas within the ACC 
were added at level three. However, inclusion of these interaction terms resulted in significant 
multicollinearity, and as such, the interactions were removed for the final model. 
 All remaining assumptions for this analysis were met. There was linearity, as assessed by 
partial regression plots and a plot of studentized residuals against the predicted values. There was 
independence of residuals, as assessed by a Durbin-Watson statistic of 1.96. There was 
homoscedasticity, as assessed by visual inspection of a plot of studentized residuals and 
unstandardized predicted values. There were no studentized deleted residuals greater than ±3 
standard deviations. The assumption of normality of residuals was met, as assessed by inspection 
of P-P Plots. 
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 At level of one of the model, modified baseline HDRS score and baseline AES score 
significantly predicted change in apathy severity. The amount of variance explained by the 
model increased by 11% following introduction of the ROIs (F(4,21)=.2, p=.94). At level two of 
the model, only modified baseline HDRS score and baseline AES score were significantly 
predictive of change in apathy severity with escitalopram treatment. 
 
VII. COGNITIVE FUNCTIONING 
Baseline  
 A two-level hierarchical linear regression was conducted to examine the association 
between measures of cognitive functioning and apathy in late-life depression (Table 9). Baseline 
AES score was included as the dependent variable in this model. Modified baseline HDRS score 
was added at level one of the model to control for the mediating effect of depression severity on 
apathy. Measures of cognitive functioning were added at level two of the model. The word-
reading, color-naming, and color/word trials of the Stroop Color and Word test were omitted to 
reduce multicollinearity.  
 All remaining assumptions were met. There was linearity, as assessed by partial 
regression plots and a plot of studentized residuals against the predicted values. There was 
independence of residuals, as assessed by a Durbin-Watson statistic of 1.87. There was 
homoscedasticity, as assessed by visual inspection of a plot of studentized residuals and 
unstandardized predicted values. There were no studentized deleted residuals greater than ±3 
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standard deviations. The assumption of normality of residuals was met, as assessed by inspection 
of P-P Plots. 
 Level one of the hierarchical regression revealed that baseline HDRS score accounted for 
5% of the variance in baseline AES score, which was not statistically significant (F(1,31)=1.54, 
p=.23). A 30% change in explained variance occurred after introducing measures of cognitive 
functioning into the model; however, this change was also non-significant (F(12,19)=.74, p=.7). 
None of the individual variables were significantly predictive of baseline AES score at any level 
of the model.  
 
Week 12 
 A two-level hierarchical linear regression was conducted to examine the association 
between measures of cognitive functioning and apathy in late-life depression following 12 weeks 
of antidepressant treatment (Table 10). Week 12 AES score was included as the dependent 
variable in this model. Modified week 12 HDRS score was added at level one of the model to 
control for the effect of depression on apathy severity. Measures of cognitive functioning were 
added at level two of the model. Because the word-reading, color-naming, and color/word trials 
of the Stroop Color and Word test were found to have collinearity, these were omitted from the 
final model. 
 All remaining assumptions were met. There was linearity, as assessed by partial 
regression plots and a plot of studentized residuals against the predicted values. There was 
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independence of residuals, as assessed by a Durbin-Watson statistic of 1.63. There was 
homoscedasticity, as assessed by visual inspection of a plot of studentized residuals and 
unstandardized predicted values. There were no studentized deleted residuals greater than ±3 
standard deviations. The assumption of normality of residuals was met, as assessed by inspection 
of P-P Plots. 
 Level one of the hierarchical regression revealed that modified week 12 HDRS score 
accounted for a significant 46% of the variance in week 12 AES score (F(1,18)=15.23, p<.01). A 
32% increase in explained variance occurred after introducing measures of cognitive functioning 
into the model, which was a non-significant change (F(12,6)=.75, p=.69). Only modified week 
12 HDRS score significantly predicted week 12 AES score in this model.  
 
Change in apathy severity  
 Two hierarchical linear regressions were conducted to examine the association between 
cognitive functioning and improvement in apathy following antidepressant treatment. The first 
included performance on cognitive measures at baseline (Table 11), and the second included 
performance on cognitive measures at week 12 (Table 12). In both models, a variable reflecting 
change in AES score between baseline and week 12 was included as the dependent variable. 
Given the association between symptom severity at baseline and symptom improvement 
following antidepressant treatment, baseline AES score and a modified baseline HDRS score 
were both included at the first level of the models. Measures of cognitive functioning were added 
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at level two of the models. The word-reading, color-naming, and color/word trials of the Stroop 
Color and Word test were omitted to reduce multicollinearity.  
 All remaining assumptions for this analysis were met. There was linearity, as assessed by 
partial regression plots and a plot of studentized residuals against the predicted values. There was 
independence of residuals, as assessed by a Durbin-Watson statistic of 2.46 for the baseline 
model and 1.55 for the week 12 model. There was homoscedasticity, as assessed by visual 
inspection of a plot of studentized residuals and unstandardized predicted values. There were no 
studentized deleted residuals greater than ±3 standard deviations. The assumption of normality of 
residuals was met, as assessed by inspection of P-P Plots. 
 Regarding cognitive functioning at baseline, the hierarchical regression revealed that at 
level one, both modified HDRS score at baseline and AES score at baseline significantly 
predicted change in AES score. Introducing cognitive measures into the model at level two 
resulted in a statistically significant increase in variance explained of 43% (F(12,5)=7.0, p=.02). 
Within this model, modified baseline HDRS score was significantly predictive of change in AES 
score, whereas baseline AES score was not. Several measures of cognition at baseline also 
significantly predicted change in apathy severity following antidepressant treatment. Individuals 
who demonstrated a greater decrease in AES score had higher baseline scores on HVLT 
immediate recall (B=2.08, SE=.81), lower baseline scores on HVLT delayed recall (B=-2.89, 
SE=.85), an increased number of HVLT false positive errors at baseline (B=-5.28, SE=2.0), 
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slower performance on TMT A (B=.45, SE=.11), and faster performance on TMT B (B=-.15, 
SE=.02).    
 Regarding cognitive functioning at week 12, both modified HDRS score at baseline and 
AES score at baseline significantly predicted change in AES score. Introducing cognitive 
measures into the model at level two resulted in a statistically insignificant increase in variance 
explained of 14% (F(12,9)=.77, p=.67). Within this model, modified baseline HDRS score 
remained significantly predictive of change in AES score, whereas baseline AES score did not. 
None of the measures of cognition at week 12 were significantly predictive of change in apathy 
severity.  
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DISCUSSION 
I. MAIN FINDINGS 
 Apathy is a common comorbidity in late-life depression (Yuen et al., 2014). Amongst 
older depressed adults, apathy is associated with a number of adverse outcomes above and 
beyond those associated with the depressive illness, such as decreased quality of life, increased 
disability, exacerbation of comorbid illness, and higher rates of mortality (Starkstein et al., 1993; 
Onyike et al., 2007; Reyes et al., 2009; Hölttä et al., 2012; Groeneweg-Koolhoven et al., 2014). 
Apathy nonetheless remains broadly overlooked and undertreated in these individuals (van 
Reekum et al., 2005). Indeed, the etiological substrates of apathy in late-life depression remain 
poorly understood, and little is known about its optimal treatment. To this end, the aim of the 
current study was to examine cortical abnormalities within the SN and RN, two brain networks 
that have a plausible association with the syndrome of apathy in older depressed adults. 
Specifically, we examined the association between AES score and cortical thickness of the right 
insula, cACC, rACC, mOFC, and lOFC in 49 individuals with late-life depression before and 
after antidepressant treatment with escitalopram. Within the SN, cortical thickness of the insula 
was significantly associated with response of apathy symptoms to escitalopram, as well as 
severity of apathy symptoms after 12 weeks of treatment. Within the RN, thickness of the rACC 
was significantly related to apathy severity before treatment was initiated. Thickness of the 
mOFC and lOFC was not associated with apathy at any time. Thickness of the cACC, which is 
involved in both salience and reward processing, was also not associated with apathy at any time. 
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Exploratory analyses examining the association between cognitive functioning and apathy 
revealed a relationship between the extents to which apathy symptoms improved with 
escitalopram treatment and several aspects of cognition, including processing speed, executive 
functioning (i.e., set shifting and source monitoring), and memory (i.e., encoding and retention of 
verbal information).  
 
II. APATHY AND LATE-LIFE DEPRESSION 
 The current results support previous reports of high comorbidity between apathy and 
depression in late-life. The prevalence of apathy in this study of older depressed adults was 46%. 
This is consistent with other studies, which have found prevalence rates of apathy in elderly 
depressed individuals of 35.5% (Yuen et al., 2014), 43% (Groeneweg-Koolhoven et al., 2015), 
and 53% (Marin et al., 1994). In contrast to other studies (Okada et al., 1997; Kant et al., 1998), 
the current results revealed a strong association between apathy and depression severity. This 
contradicts the premise that apathy is a clinically distinct entity that should be considered in 
isolation from depression (Yuen et al., 2014). However, depressive symptoms were found to be 
significantly more responsive to antidepressant treatment than symptoms of apathy. In fact, the 
response of apathetic participants to antidepressant medication in the current study was less than 
reported in previous studies (Bolling and Kohlenberg, 2004; Yuen et al., 2014). Apathy persisted 
in 27.3% of older depressed adults following treatment with escitalopram. In contrast, another 
study documented persistence of apathy in 18.6% of older depressed adults (Bolling and 
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Kohlenberg, 2004), and in a study with a smaller sample of older depressed adults that 
overlapped partially with the sample included in the current study, apathy persisted in 15.6% of 
older depressed adults (Yuen et al., 2014). This differential response of apathetic and depressive 
symptoms to antidepressant treatment suggests that apathy has neurobiological underpinnings 
that are distinct from depression, and may not be adequately targeted with SSRI treatment.  
 
III. CORTICAL THICKNESS 
 The current findings suggest a role for salience processing in the clinical expression of 
apathy. Results indicated that a decrease in cortical thickness of the insula is associated with poor 
response of apathy symptoms to antidepressant treatment, as well as with the severity of apathy 
symptoms following treatment. Baseline apathy severity was not associated with cortical 
thickness of the insula, which suggests that the SN may be involved specifically in the 
mechanism by which antidepressant medication alleviates apathy symptoms, but not in the 
expression of apathy symptoms per se.    
 These findings are consistent with prior studies that used a partially overlapping sample 
(Alexopoulos et al., 2013; Yuen et al., 2014). In one study, depressed older adults with apathy 
had an abnormal pattern of rsFC between the insula, dACC, NAcc, and several other subcortical 
structures (Alexopoulos et al., 2013). In another study, apathetic individuals with late-life 
depression showed a decrease in rsFC within the SN, and an increase in rsFC between the right 
AI and right DLPFC compared to their non-apathetic counterparts (Yuen et al., 2014).  
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 Other studies provide further support for the involvement of neuroanatomical 
abnormalities of the AI and SN in apathy (Benoit et al., 2004; Alzahrani et al., 2016). For 
example, electrical brain stimulation of areas within the SN has been reported to elicit a sense of 
motivation and determination (Greicius et al., 2004; Parvizi et al., 2013). Rodents with lesions in 
the SN give up more easily when required to climb over a barrier in order to reach a food pellet, 
which suggests that these animal may experience the equivalent of apathy symptoms in humans 
(Rudebeck et al., 2006). Finally, a graph theory study examining apathy and depression in 
middle-aged and older adults found that while depression was characterized by increased 
processing within the SN, apathy was associated with decreased processing within the SN 
(Onoda and Yamaguchi, 2015).  
 The right AI plays a prominent role in identifying internal and external stimuli that may 
facilitate or interfere with goal-directed activity. Upon detection of such cues, it activates other 
networks that adjust homeostatic states, emotional experiences, cognitive processes, and overt 
behaviors in order to stay on task (Gehring et al., 1993; Dehaene et al., 1994; Klein et al., 2007; 
Lamm and Singer, 2010). To this end, the AI receives communications regarding interoceptive 
states from the PI and other sensory areas, consolidates this information with information 
regarding the external environment, memories, and internal states, and activates brain areas 
involved in emotion, higher order cognition, and complex behavior, such as the amygdala and 
ventral striatum (Craig, 2002; Critchley et al., 2004). As such, apathy might be the consequence 
of decreased identification of events that are relevant for maintaining goal-directed behavior. 
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 The finding that rACC thickness is associated with apathy severity in untreated patients 
with late-life depression is indicative of a role for the RN in the clinical expression of apathy 
symptoms. Of note, although thickness of the right rACC was not associated with treatment 
response or persistence in this study, a prior study using a partially overlapping sample revealed 
that response of apathy symptoms to SSRI treatment was associated with larger left posterior 
subgenual cingulate volume (Yuen et al., 2014). 
 The rACC is activated in the context of emotionally-salient distracters (Whalen et al., 
1998; Shin et al., 2001; Vuilleumier et al., 2001; Bishop et al., 2004; Etkin et al., 2006), and 
plays a crucial role in the affective evaluation of experienced and anticipated rewards and losses 
(Bush et al., 2000; Etkin et al., 2011; Toda et al., 2012). In addition, the rACC is involved with 
the regulation of affective responses to feedback, for example when an individual interprets a 
loss as a frustrating event (Taylor et al., 2006). Thus, the current results suggest that impairment 
in an individual’s ability to attribute emotional valence to rewards and losses may contribute to 
the decline in motivation that characterizes apathy.  
 Interestingly, abnormalities of the rACC are also implicated in depression. The rACC 
plays a role in the resolution of emotional conflict, as well as the inhibition of task-irrelevant 
emotional experiences, through top-down, inhibitory modulation of the amygdala and other 
limbic regions (Devinsky et al., 1995; Whalen et al., 1998; Bush et al., 2000; Phan et al., 2002). 
Depression is associated with hypoactivation of the rACC and hyperactivity of the amygdala 
(Hull, 2002). Hypoactivity of the rACC is predictive of poor response to antidepressant treatment 
 	  	  	  
	  	  	  	  
67 
(Kumari et al., 2003), and higher rACC activation is associated with a more favorable response 
(Etkin et al., 2006). Thus, it is possible that deficient limbic inhibition by the rACC may result in 
a preponderance of negative experiences, which may interfere with the association of positive 
valence with potential future rewards, thereby depleting an individual of the motivation to 
dedicate resources to the attainment of those rewards. This may play a role in the development of 
both depression and apathy (Etkin et al., 2006), and may explain the frequent co-occurrence of 
apathy and depression in older adults.       
 The rACC has strong connections to the AI (Whalen et al., 1998; Shin et al., 2001; 
Vuilleumier et al., 2001; Bishop et al., 2004; Etkin et al., 2006). Together, these structures 
contribute to the attribution of incentive salience to stimuli. Thus, abnormalities in the processing 
of incentive salience may contribute to the clinical expression of apathy. Individuals with apathy 
may not experience the motivational drive and behavioral activation that is associated with 
reward anticipation in non-apathetic individuals. However, from this perspective it is noteworthy 
that the cACC was not predictive of apathy in the current study. Compared to the cACC, the 
rACC is more prominently implicated in affect regulation and has strong connections to areas 
that underlie emotional processes, such as the amygdala and hypothalamus (Mansouri et al., 
2009), whereas the cACC plays a bigger role in cognition and has strong connections with brain 
regions that mediate cognitive control processes, such as the DLPFC. This suggests that while 
incentive salience may be impaired in older depressed adults with apathy, the lack of motivation 
in these individuals is likely to be specific to an inability to associate desire with a reinforcing 
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stimulus, as opposed to an impairment in the formulation and execution of activity required to 
attain a reinforced goal.  
 Neither the medial nor the lateral areas of the OFC were associated with apathy severity 
at baseline, week 12, or response to treatment. The OFC is activated by stimuli such as touch, 
taste, smell, and more abstract reinforcements such monetary gains and losses, and integrates this 
information in order to create predictions of losses and rewards (Kringelbach and Rolls, 2004; 
Rolls, 2004). Damage to the OFC impairs the learning and forgetting of associations between 
stimuli and their potentially reinforcing or aversive qualities. Furthermore, individuals with 
damage to the OFC are less emotionally reactive to rewarding stimuli and have difficulty 
evaluating whether choices made have positive or negative outcomes (Bechara et al., 2000; 
Bechara, 2004). Thus, individuals with lesions to the OFC are unable to adjust their actions to 
task-related changes in the environment that may effect the attainment of rewards (Kringelbach 
and Rolls, 2004; Rolls, 2004). Given these functions of the OFC, combined with the current non-
significant findings, it appears that learning of reward associations may not be required for the 
lack of motivation that is associated with apathy.   
 
IV. COGNITIVE FUNCTIONING 
 Regarding exploratory analyses, several aspects of baseline cognition were related to 
improvement in apathy severity following escitalopram treatment, including processing speed, 
executive functioning (i.e., set shifting and source monitoring), and memory (i.e., encoding and 
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retention of verbal information). These associations with apathy were specific to change in 
symptom severity with antidepressant treatment, and were not present either before or after 
antidepressant treatment. Thus, it is possible that the structural abnormalities underlying 
impairment in these cognitive domains interfere with the mechanism by which serotonergic 
antidepressant medication alleviates apathy symptoms in older depressed adults, but are not 
directly associated with the clinical expression of apathy.      
In the current study, decreased processing speed was associated with a weaker response 
of apathy symptoms to antidepressant treatment. Other studies have found similar associations 
between processing speed and apathy. One study examining processing speed in apathetic 
individuals with depression found an additive, detrimental effect of apathy on processing speed 
(Cohen et al., 2015). Another study examining apathy in individuals with HIV demonstrated that 
apathy attenuated age-related declines in processing speed (Shapiro et al., 2013). Finally, a case 
study of an individual with apathy secondary to radiation necrosis of the bilateral mesial frontal 
lobe reported reduced processing speed in the context of otherwise intact functioning of the 
cognitive processes typically associated with the frontal lobe (Kirsch-Darrow et al., 2006).  
Processing speed is often considered a fundamental aspect of cognition. Although 
processing speed is typically associated with overall white matter integrity (Penke et al., 2010), 
decreased processing speed may also be associated with more focal white matter abnormalities. 
For example, a study that applied VBM to diffusion tensor images from 39 healthy, adult 
participants found an association between processing speed and structural integrity of white 
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matter tracts in only the parietal cortex, temporal cortex, and left middle frontal gyrus (Turken et 
al., 2008). Decreased processing speed may interfere with many other cognitive processes, 
including those found to be associated with apathy in the current study. However, controlling for 
processing speed in the current study did not remove the relation between other cognitive 
difficulties and apathy. These associations therefore likely exist independent of changes in 
processing speed.  
The current findings revealed a relationship between set shifting and the response of 
apathy symptoms to antidepressant treatment. However, contrary to expectations, the results 
revealed that individuals with better set-shifting ability had a weaker response of apathy 
symptoms to antidepressant treatment, which is in contrast to prior to studies. For example, 
several studies examining set shifting in individuals with apathy and comorbid depression have 
found that set shifting impairments are specific to apathy, and are unrelated to depression 
(Varanese et al., 2011; Klaasen et al., 2017). Set shifting is typically associated with activation of 
the DLPFC (Yochim et al., 2007). For example, in a study of 101 participants with various types 
of dementia, set shifting was associated with bilateral frontal lobe volumes, but not with cortical 
volume in any other brain region (Kramer et al., 2007). An fMRI study of set shifting in 12 
healthy adults found activation in favor of the left hemisphere, most notably in regions of the 
frontal lobe, and in the middle temporal and superior temporal gyrus (Zakzanis et al., 2005). 
Associations between set shifting and areas of the left, as opposed to the right, hemisphere were 
also found in another, similar study (Moll et al., 2002). In this study, set shifting was specifically 
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associated with the left DLPFC and medial prefrontal cortex. Thus, the current results, taken 
together with other findings of  the neuroanatomical localization of set shifting abilities, suggest 
a possible role for the left hemisphere in apathy of late-life depression, particularly in treatment 
response to antidepressant medication.   
Interestingly, there was no association between cognitive flexibility, perseveration, and 
apathy improvement in response to antidepressant treatment in the current study, even though 
these aspects of cognition are often considered synonymous with set shifting. Similar to set 
shifting, cognitive flexibility and perseveration are subsumed primarily by areas in the prefrontal 
cortex, particularly the DLPFC (Mukhopadhyay et al., 2007; Head et al., 2009; Konishi et al., 
1998; Lombardi et al., 1999; Kleinman et al., 2013). The DLPFC is one of the key nodes of the 
CCN (Langenecker et al., 2007). Within the CCN, the ACC monitors for the presence of conflict, 
and activates the DLPFC to resolve the conflict using adjustment processes, for example when 
there is a need for switching attentional focus based on task requirements (Milham et al., 2003; 
Erickson et al., 2004). Although the CCN has been implicated in treatment non-response in older 
depressed adults (Pimontel et al., 2012), the current results provide inconclusive results 
regarding the involvement of the CCN in the persistence of apathy in older depressed adults.  
 Source monitoring was associated with decreased improvement in apathy severity 
following antidepressant treatment in the current study. Impaired source monitoring is associated 
with a disturbance in the process of conjoining knowledge of information with details about the 
source of that information (Johnson and Raye, 1981; Johnson et al., 1993; Johnson, 1997). 
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Source monitoring is considered an executive control process that underlies memory, as opposed 
to a primary memory function, given that it is more prominently associated with activation in 
areas of the brain that are responsible for frontally-mediated, “higher order” cognition, rather 
than with areas of the temporal lobe that are typically involved in primary memory processes 
such as learning and retention of information. For example, while amnestic individuals with 
lesions in the mesial temporal lobe demonstrate impairment in encoding, consolidation, and 
retrieval, they do not necessarily have difficulty with source monitoring (Kopelman et al., 1997). 
In contrast, individuals with frontal lobe lesions demonstrate impaired source monitoring, 
including extremely high rates of false positive errors (Buckner et al., 1995; Parkin et al., 1995; 
Schacter et al., 1996; Kopelman et al., 1997; Schacter and Coyle, 1997). Individuals with lesions 
to the right OFC and anterior prefrontal cortex are particularly susceptible to source monitoring 
errors (Buckner et al., 1995; Parkin et al., 1995; Schacter et al., 1996; Schacter and Coyle, 1997). 
Give the lack of an association between the OFC and apathy in the current study, these results do 
not fully explain the association between source monitoring and change in apathy severity with 
antidepressant treatment.  
 Several primary memory processes were also associated with response of apathy 
symptoms to antidepressant treatment, namely encoding and retention of verbal information. 
Interestingly, a stronger response of apathy symptoms to antidepressant treatment was associated 
with better encoding of verbal information, while individuals whose apathy symptoms responded 
to antidepressant medication demonstrated weaker retention of information. Other studies have 
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also found associations between these memory processes and apathy. In one study of 38 
individuals with schizophrenia and comorbid apathy, apathy severity was associated with 
performance on a measure of verbal learning and recall (Roth et al., 2007). In a study of 48 
individuals with PD, apathy was more strongly associated with performance on a measure of 
immediate recall than with performance on a wide variety of other neuropsychological tasks, 
including processing speed, attention, working memory, and executive functioning (Varanese et 
al., 2011). Interestingly, in a study of 53 individuals with severe TBI,  only the cognitive 
dimension of apathy was associated with weak information encoding, whereas no such 
association was found for the behavioral and emotional dimensions of apathy (Andersson and 
Bergedalen, 2002).     
 Deficits in an individual’s ability to retrieve information may mimic difficulties with 
retention (Stuss and Knight, 2013). In these cases, individuals are unable to access information 
that was nonetheless learned and retained over time. Individuals may perform poorly on 
spontaneous recall tasks, while their recall will improve when provided with recognition cues 
that decrease the need for self-guided retrieval. Similar to the aforementioned source monitoring, 
retrieval is considered an executive control process that underlies memory, as opposed to a 
primary memory function, given that retrieval of information is subsumed by prefrontal areas of 
the brain that are responsible for executive processes, as opposed to the areas of the temporal 
lobe that are primarily involved in encoding and retention (Stuss and Knight, 2013). For 
example, in a study examining individuals with frontal lobe lesions, lesions located in the left 
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posterior DLPFC and the posterior medial frontal lobe demonstrated impairment in both learning 
and retention, but this was secondary to retrieval difficulties (Alexander et al., 2003). Given that 
true positive responses on a recognition task were not associated with treatment response of 
apathy symptoms in the current study, it is possible that frontally-mediated retrieval deficits 
underlie the association between retention and apathy in older depressed adults.  
 Contrary to expectation, there was no significant association between apathy and 
cognitive inhibition on the Stroop Color and Word task. Cognitive inhibition requires activation 
of the CCN, which involves both conflict detection and response regulation. The ACC is 
commonly regarded as the main structure involved in conflict detection, and abnormalities 
within the ACC may therefore result in impairment in cognitive inhibition. Within this context, 
the rostral and caudal regions of the ACC play different roles, such that the rACC is involved in 
processing emotional conflicts, whereas the cACC is involved in processing non-emotional 
conflicts. These distinctions are evident on tasks assessing cognitive inhibition. While the need 
for cognitive inhibition on the Stroop Color and Word task activates the cACC, the rACC is 
activated when there is a demand for inhibition of an emotional response. Two studies found 
greater activation of the rACC than the cACC during a task that required individuals to 
categorize images of faces based on their emotional expression (e.g., happy or sad), while 
ignoring words describing congruent or incongruent emotions (e.g., “HAPPY” or “SAD”) (Etkin 
et al., 2006; Egner, 2008). Thus, the lack of an association between cortical thickness of the 
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cACC and apathy in the current study may explain the additional absence of a correlation with 
performance on the Stroop Color and Word task.  
 
V. CLINICAL IMPLICATIONS 
 The current findings have important clinical implications. First, the findings support the 
clinical and etiologic distinction between apathy and depression in older adults. The current 
results also add to the literature suggesting that SSRI treatment does not adequately target apathy 
symptoms in older depressed adults. Indeed, other studies demonstrate that treatment of older 
depressed adults with SSRIs may, in fact, exacerbate symptoms of apathy (Barnhart et al., 2004; 
Wongpakaran et al., 2007; Leontjevas et al., 2013; Lanctôt et al., 2017). Thus, taken together 
with prior research, the current results support the need for an alternative approach to the 
treatment of apathy in late-life depression.  
 The finding that apathy in older depressed adults may be associated with impaired 
incentive salience suggests a role for dopamine abnormalities in the clinical expression of 
apathy. While dopamine is historically considered to be associated with reward processing in 
general, more recent studies suggest that dopamine is specifically involved in the processing of 
incentive salience, such that dopaminergic transmission in the mesolimbic pathway modulates 
reward attribution and anticipation (i.e., “wanting”), as opposed to hedonistic experiences (i.e., 
“liking”) (Berridge and Robinson, 1998; Berridge, 2007). Dopaminergic abnormalities in the 
mesolimbic pathway may therefore be associated with an impaired experience of motivational 
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value, which, in turn, may underlie the clinical expression of apathy symptoms in older adults 
with late-life depression.  
 The possible involvement of dopaminergic abnormalities may also explain the poor 
response of apathy symptoms to SSRI treatment. There is an intricate balance between 
monoaminergic neurotransmitters, such that serotonin has an inhibitory effect on dopaminergic 
activity in the frontal lobe and striatum. Thus, the increase in serotonin that results from SSRI 
treatment may lead to a decrease in dopamine transmission (Kapur and Remington, 1996), 
thereby preventing remission of apathy symptoms, or even exacerbating these symptoms.  
  Studies examining the role of dopamine in apathy have consistently found associations 
between decreased activity in dopaminergic systems and increased apathy. For example, a 
comprehensive review examining the association between dopamine and symptoms of apathy in 
individuals with AD concluded that dopaminergic abnormalities are associated with the clinical 
expression of apathy in these individuals (Mitchell et al., 2010). A study examining apathy 
severity and striatal dopamine uptake in individuals with AD and LBD found a relationship 
between apathy and dopamine transporter levels, suggesting that apathy may be associated with 
loss of dopaminergic neurons in the striatum (David et al., 2007). Similar results were found in 
another study examining the association between apathy and dopamine transporter levels. In this 
study, apathetic individuals with PD had less dopamine uptake in the striatum than their non-
apathetic counterparts, most notably in the right caudate (Santangelo et al., 2015).  
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 Despite evidence of dopaminergic abnormalities in apathy, there are limited clinical trials 
examining the use of dopamine agonists for the treatment of apathy. In a case study examining 
the use of ropinirole in an individual who developed apathy after a cerebral infarction in the 
prefrontal cortex, improvement was seen in “verbal output and spontaneity in daily life” 
following treatment, and this was associated with an increase in blood flow in the prefrontal 
cortex and basal ganglia (Kohno et al., 2009). In a 12-week randomized controlled trial 
examining piribedil for the treatment of apathy in individuals with PD, quantitative ratings of 
apathy symptoms on the Starkstein Apathy Scale improved by 46.6% in those treated with 
piribedil, whereas ratings of apathy symptoms on this scale worsened by 2.3% in those treated 
with placebo (Thobois et al., 2013). Modafinil has been shown to effectively decrease apathy 
symptoms in AD (Frakey et al., 2012). Bromocriptine and amantadine have been studied 
primarily in individuals with TBI, stroke, and PD. Results indicate decreased apathy, and 
increased motivation, initiative, and spontaneity following treatment with this medication (van 
Reekum et al., 2005). Methylphenidate and d-amphetamine have been examined in a wide range 
of neurologic disorders, including AD, stroke, Wilson’s disease, and HIV-related dementia, and 
have been shown to decrease apathy and social withdrawal, and increase motivation, physical 
activity, attention to personal hygiene, and independence in activities of daily life (Herrmann et 
al., 2008; Padala et al., 2010; Martin et al., 1995; Bonelli and Cummings, 2007). 
 In addition to dopaminergic agents, the use of acetylcholinesterase inhibitors is also of 
interest for the treatment of apathy in older depressed adults, given that dopamine depletion may 
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be alleviated by an increase in acetylcholine (Martorana et al., 2009). Indeed, several studies 
examining the use of acetylcholinesterase inhibitors for the treatment of cognitive decline in 
individuals with neurodegenerative disorders have found a response of apathy symptoms to 
treatment (Bonelli and Cummings, 2007; Cummings and Back, 1998; Kaufer et al., 1998). A 
meta-analysis of randomized controlled trials concluded that metrifonate was useful for the 
decrease of apathy severity in individuals with AD (Lopez-Arrieta and Scheider, 2006). Studies 
have also demonstrated beneficial effects of tacrine (Kaufer et al., 1996) and donepezil 
(Waldemar et al., 2011) on apathy symptoms in individuals with AD. Finally, apathy is 
effectively treated with rivastigmine in individuals with PD (Moretti et al., 2017) and LBD 
(McKeith et al., 2010). 
 In summary, there is strong, albeit limited data suggesting a crucial role of dopaminergic 
abnormalities in the clinical expression of apathy symptoms, as well the utility of dopamine-
enhancing agents for the treatment of apathy. These agents include not only medications that 
directly increase dopaminergic activity, but also agents that indirectly effect dopamine 
transmission, such as acetylcholinesterase inhibitors.  
  
VI. LIMITATIONS 
 The results of the current study should be interpreted in the context of several limitations. 
First and foremost, the number of participants was relatively small, particularly in the group of 
apathetic individuals at week 12. This limitation is further complicated by the large number of 
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variables in the regression analyses, which may have resulted in overfitting. Regarding the 
neuroanatomical regions included in the analyses, use of a preexisting atlas with parcellations 
based on morphology, as opposed to functional or connectivity properties, may have decreased 
the accuracy of the ROIs included in the analyses. For example, the literature clearly stipulates a 
more pronounced role for the AI in salience processing, as opposed to the PI. However, the 
Desikan-Killiany atlas does not distinguish between anterior and posterior areas of the insula, 
and as such, the ROI used in the current study included the entire insular region. It should also be 
noted that cortical thickness is merely an indirect measure of a presumed disease-related process, 
as is the case with all imaging-based modalities. Specifically, a decrease in cortical thickness is 
considered unfavorable, in that it presumably reflects a detrimental decline of healthy cerebral 
tissue.  However, cortical thickness is not a direct measure of cerebral health, and as such, it may 
in fact not be a valid indice of pathology. Finally, although all participants in the current study 
were screened for dementia, it cannot be ruled out that some individuals may have been in a 
prodromal phase of dementia. Thus, it cannot be ruled out that all individuals with apathy were 
affected by the same disease processes. 
 
VII. FUTURE DIRECTIONS 
 The current finding of an association between apathy and cortical thickness within the SN 
and RN in older depressed adults contributes to the literature aiming to extricate the 
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neuroanatomical mechanisms underlying apathy. However, there is still a grave need for further 
examination of causal factors underlying apathy, as well as of potential treatment modalities.  
 Further exploration of the neuroanatomical abnormalities associated with apathy in late-
life depression is warranted. First and foremost, long-term follow-up studies with a larger 
number of participants will allow  the relationship between apathy and abnormalities within the 
SN and RN to be explored with more confidence. In addition, there is a need for examination of 
the role of the left hemisphere in the clinical expression of apathy. The current results revealed 
an association between set shifting and apathy, which, taken together with other findings of  the 
neuroanatomical localization of set shifting abilities, suggests that there may be a possible role 
for the left hemisphere in the apathy of late-life depression. In addition, although the right insula 
is more commonly associated with salience processing than the left insula, there is also evidence 
of specialized hemispheric involvement. While the right insula is associated with processing of 
sympathetic arousal and aversive stimuli, such as disgust and anxiety, the left insula may be 
involved in parasympathetic nervous functions and processing of positive emotions (Cauda et al., 
2011). Finally, although thickness of the right rACC was not associated with treatment response 
or persistence in this study, a prior study using a partially overlapping sample revealed that 
response of apathy symptoms to SSRI treatment was associated with larger left posterior 
subgenual cingulate volume (Yuen et al., 2014). 
 Studies examining white matter abnormalities in older depressed adults with apathy will 
also be important.  It is possible that apathy may be caused by disturbances in the connections 
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within and between structures of the SN and RN, while the actual structures may be unaffected. 
This is suggested by the current finding of decreased processing speed in apathy, which is often 
associated with diffuse disturbances of white matter integrity. Finally, the possible involvement 
of subcortical areas in apathy should be explored. For example, the ventral striatum is involved 
in both salience and reward processing (Haber, 2011; Menon, 2015), and may therefore 
contribute to the clinical expression of apathy in late-life depression.   
Future studies examining neuroanatomical abnormalities associated with apathy should 
distinguish between the different dimensions of the syndrome, given that different dimensions of 
apathy may be associated with distinct neuroanatomical abnormalities. For example, there is 
evidence that emotional apathy may be associated with abnormalities in the orbital and medial 
prefrontal cortex, while cognitive apathy may be associated with abnormalities in the basal 
ganglia (i.e., caudate nucleus, globus pallidus, substania nigra) and anterior thalamic nuclei, and 
behavioral apathy may be associated with abnormalities in the caudate nucleus, globus pallidus, 
medial dorsal thalamus, and dorsal and ventral ACC (Levy and Dubois, 2006). In addition, one 
study found that cognitive apathy was associated with weak performance on information 
encoding, whereas no such association was found for the behavioral and emotional dimensions 
of apathy (Andersson and Bergedalen, 2002). This further supports differing etiologies for the 
different dimensions of apathy. Given current findings indicating a role for the rACC in apathy, 
but not the cACC, a more fine-tuned perspective on the involvement of these cortical structures 
may be provided by contrasting the emotional and cognitive dimensions of apathy. 
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Regarding treatment, future research should focus on examining the role of dopamine 
deficiency in the clinical expression of apathy. For example, clinical trials should examine the 
efficacy of dopaminergic agents in older depressed adults whose apathy symptoms do not 
respond to SSRI medication, as well as the association between abnormalities within the SN and 
RN and response to dopaminergic medications. 
 Finally, regarding the cognitive characteristics of apathy in late-life depression, there are 
several additional measures that may be of interest. Future studies should examine performance 
of apathetic individuals on emotion-based interference tasks. Given the results of the current 
study demonstrating abnormalities of the rACC in individuals with apathy, it is expected that 
these individuals will perform more poorly on such a task than their non-apathetic counterparts. 
Another task of interest is the Iowa Gambling Task (Ligthart et al., 2012; Bechara et al., 1997). 
The IGT is a face-valid measure that evaluates reward-based decision-making. This task requires 
individuals to select cards from four decks, each resulting in a monitory reward, loss, or both. 
Two decks contain cards that with smaller monetary rewards but also fewer losses, which will 
result in a net gain over time. The other two decks contain cards with larger monetary gains and 
greater losses, resulting in a net loss over time. While healthy individuals often choose 
disadvantage decks initially, most will eventually switch to the more advantageous decks. 
However, apathetic individuals consistently select cards from the less advantageous decks, 
suggesting impaired incentive salience processing in these individuals (Njomboro et al., 2012; 
Bayard et al., 2014). Furthermore, apathy and impaired performance on the IGT are both 
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associated with abnormalities in the dopaminergic mesolimbic pathway, which subsumes 
incentive salience processing. Specifically, dopamine depletion impairs performance on the IGT, 
while increased dopamine improves IGT performance (Bechara et al., 2001). Thus, examination 
of IGT performance  in older depressed adults with apathy will not only aid in characterizing the 
clinical presentation of apathy, but may also provide further insight into the underlying etiology 
of this syndrome.  
 
VIII. CONCLUSION 
  In summary, the results of this study support the premises that apathy is a commonly 
occurring syndrome in late-life depression that is nonetheless etiologically distinct, and that may 
not be adequately targeted with SSRI treatment. Indeed, the neuroanatomical involvement of the 
AI and rACC in apathy, as well as a possible role for impaired processing of emotionally-based 
incentive salience, suggest that dopaminergic agents may be more effective for the treatment of 
apathy. To this end, future research examining apathy in individuals with late-life depression 
should focus on exploring deficits in connectivity within and between the SN and RN, as well as 
on associations between apathy, emotionally-based tasks, and possible pathophysiological 
abnormalities. Given the broad-ranging detrimental effects of apathy in older depressed adults on 
both an individual and a societal level, further examination of clinical and neuropathological 
characteristics, as well as of treatment and prevention modalities, is warranted.   
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APPENDIX A - TABLES AND GRAPHS 
 
I. DEMOGRAPHICS 
Table 1. Key study variable for all study participants 
 All Controls Depressed p-value 
N 89 40 49  
Age 70.44 (6.13) 70.7 (6.3) 70.22 (6.04) .718 
Gender (% female) 57 60 55 .64a 
Education 16.29 (3.04) 16.55 (2.6) 16.08 (3.37) .473 
AES BL 30.29 (10.67) 22.93 (4.49) 36.7 (10.36) >.01b 
HDRS BL 13.06 (10.61) 1.85 (1.67) 22.2 (3.74) >.01b 
MMSE BL 28.26 (1.29) 28.5 (1.09) 28.06 (1.42) -.11 
AES w12 27.38 (7.64) 23.5 (2.12) 27.63 (7.81) .47 
HDRS w12 4.68 (4.55) 2.74 (2.22) 6.91 (5.74) >.01b 
MMSE w12 28.23 (1.31) 28.16 (3.37) 28.3 (1.1) .67 
Insula Thickness 2.77 (.2) 2.77 (.18) 2.77 (.22) .9 
rACC Thickness 2.7 (.24) 2.69 (.21) 2.72 (.27) .54 
cACC Thickness 2.57 (.3) 2.53 (.26) 2.6 (.33) .31 
lOFC Thickness 2.4 (.18) 2.38 (.16) 2.4 (.2) .66 
mOFC Thickness 2.26 (.18) 2.21 (.13) 2.3 (.21) <.01b 
Note. All data presented as mean (SD) unless otherwise specified; aFisher’s exact test; bWelch’s t-test; all other p-
values are student’s t-test results; AES=Apathy Evaluation Scale; HDRS=Hamilton Depression Rating Scale; 
MMSE=Mini Mental Status Exam; rACC=Rostral Anterior Cingulate Cortex; cACC=Caudal Anterior Cingulate; 
lOFC=Lateral Orbitofrontal Cortex, mOFC=Medial Orbitofrontal Cortex 
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Table 2. Key study variables at baseline  
 All Controls Depressed 
No Apathy 
Depressed 
Apathy 
p-value 
N 85 39 25 21  
Age 70.29 (6.11) 70.72 (6.38) 68.48 (5.08) 71.67 (6.48) .18 
Gender (% 
female) 
58 62 60 48 .56 
Education 16.26 (3.09) 16.56 (2.63) 16.68 (2.81) 15.19 (3.98) .19 
AES BL 30.2 (10.7) 22.54 (3.81)b 29.24 (6.27) b 45.57 (6.49) b <.01a 
HDRS BL 12.94 (10.7) 1.85 (1.69)c,d 21.68 (3.18)c 23.14 (4.26)d <.01a 
MMSE BL 28.27 (1.31) 28.49 (1.1) 27.96 (1.49) 28.24 (1.45) .3 
AES w12 26.84 (7.74) 23.5 (2.12) 24.56 (5.83) 31.18 (9.44) .06 
HDRS w12 4.49 (4.49) 2.68 (2.22)c 6.17 (4.48)c 7.46 (6.83) <.01a 
MMSE w12 28.23 (1.33) 28.13 (1.53) 28.35 (1.17) 28.31 (1.11) .85 
Insula 
Thickness 
2.78 (.2) 2.76 (.18) 2.8 (.2) 2.77 (.23) .73 
cACC Thickness  2.57 (.3) 2.53 (.26) 2.67 (.27) 2.53 (.39) .13 
rACC Thickness 2.71 (.25) 2.69 (.21) 2.79 (.28) 2.67 (.25) .15 
lOFC Thickness 2.4 (.18) 2.38 (.16) 2.4 (.21) 2.43 (.18) .6 
mOFC 
Thickness 
2.26 (.18) 2.21 (.13) 2.29 (.19) 2.31 (.23) .06 
Note. All data presented as mean (SD) unless otherwise specified; aWelch’S ANOVA and Games-Howell Post Hoc 
test; all other p-values are one-way ANOVA results with Tukey’s HSD Post Hoc test; sSignificant differences 
between all three comparison groups; sSignificant difference between controls and depressed older adults with no 
apathy at baseline; dSignificant difference between controls and older depressed adults with apathy at baseline; 
AES=Apathy Evaluation Scale; HDRS=Hamilton Depression Rating Scale; MMSE=Mini Mental Status Exam; 
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rACC=Rostral Anterior Cingulate Cortex; cACC=Caudal Anterior Cingulate Cortex; lOFC=Lateral Orbitofrontal 
Cortex, mOFC=Medial Orbitofrontal Cortex 
 
II. SALIENCE NETWORK 
Table 3. Hierarchical linear regression predicting baseline apathy severity  
  R R2 ΔR2 F β 
Step 1  .4 .16 .16* 3.96*  
 mHDRS baseline     .37* 
 Mean thickness     -.1 
Step 2  .41 .17 .02 2.11  
 mHDRS baseline     .36* 
 Mean thickness     .01 
 Insula thickness     -.6 
 cACC thickness     .02 
Note. N=46; *p<.05, **p<0.01; mHDRS=Modified Hamilton Depression Rating Scale; cACC=Caudal Anterior 
Cingulate Cortex 
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Graph 1. Scatterplot of Salience Network and AES Baseline 
 
Note. N=46; AES=Apathy Evaluation Scale; cACC=Caudal Anterior Cingulate Cortex 
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Table 4. Hierarchical linear regression predicting week 12 apathy severity  
  R R2 ΔR2 F β 
Step 1  .67 .44 .44** 9.19**  
 mHDRS week 12     .67** 
 Mean thickness     .02 
Step 2  .76 .58 .13 7.09**  
 mHDRS week 12     .55** 
 Mean thickness     .32 
 Insula thickness     -.51* 
 cACC thickness     -.03 
Note. N=26; *p<.05, **p<0.01; mHDRS=Modified Hamilton Depression Rating Scale; cACC=Caudal Anterior 
Cingulate Cortex 
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Graph 2. Scatterplot of Salience Network ROIs and AES Week 12 
 
Note. N=26; AES=Apathy Evaluation Scale; cACC=Caudal Anterior Cingulate Cortex 
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Table 5. Hierarchical linear regression predicting change in apathy severity  
  R R2 ΔR2 F β 
Step 1  .84 .7 .7** 19.12**  
 mHDRS baseline     .5** 
 AES baseline     .46** 
 Mean thickness     .14 
Step 2  .89 .79 .09* 16.79**  
 mHDRS change     .53** 
 AES baseline     .52** 
 Mean thickness     -.14 
 Insula thickness     .43** 
 cACC thickness     -.03 
Note. N=29; *p<.05, **p<0.01; mHDRS=Modified Hamilton Depression Rating Scale; AES=Apathy Evaluation 
Scale; cACC=Caudal Anterior Cingulate Cortex 
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Graph 3. Scatterplot of SN ROIs and AES Change 
 
Note. N=29; AES=Apathy Evaluation Scale; Insula=Anterior Insula; cACC=Caudal Anterior Cingulate Cortex 
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III. REWARD NETWORK 
Table 6. Hierarchical linear regression predicting baseline apathy severity  
  R R2 ΔR2 F β 
Step 1  .4 .16 .16* 3.96*  
 mHDRS baseline     .37* 
 Mean thickness     -.1 
Step 2  .51 .26 .1 2.22  
 mHDRS baseline     .4** 
 Mean thickness     -.06 
 lOFC thickness     .23 
 mOFC thickness     .01 
 rACC thickness     -.38* 
 cACC thickness     .08 
Note. N=46; *p<.05, **p<0.01; mHDRS=Modified Hamilton Depression Rating Scale; lOFC=Lateral Orbitofrontal 
Cortex, mOFC=Medial Orbitofrontal Cortex, rACC=Rostral Anterior Cingulate Cortex, cACC=Caudal Anterior 
Cingulate Cortex 
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Graph 4. Scatterplot of RN ROIs and AES Baseline 
 
Note. N=46; AES=Apathy Evaluation Scale; lOFC=Lateral Orbitofrontal Cortex, mOFC=Medial Orbitofrontal 
Cortex, rACC=Rostral Anterior Cingulate Cortex, cACC=Caudal Anterior Cingulate Cortex 
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Table 7. Hierarchical linear regression predicting week 12 apathy severity 
  R R2 ΔR2 F β 
Step 1  .67 .44 .44** 9.19**  
 mHDRS week 12     .67** 
 Mean thickness     .02 
Step 2  .68 .47 .02 2.79*  
 mHDRS week 12     .65** 
 Mean thickness     .02 
 lOFC thickness     .09 
 mOFC thickness     .03 
 rACC thickness     -.2 
 cACC thickness     .00 
Note. N=26; *p<.05, **p<0.01; mHDRS=Modified Hamilton Depression Rating Scale; lOFC=Lateral Orbitofrontal 
Cortex, mOFC=Medial Orbitofrontal Cortex, rACC=Rostral Anterior Cingulate Cortex, cACC=Caudal Anterior 
Cingulate Cortex 
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Graph 5. Scatterplot of RN ROIs and AES Week 12 
 
Note. N=26; AES=Apathy Evaluation Scale; lOFC=Lateral Orbitofrontal Cortex, mOFC=Medial Orbitofrontal 
Cortex, rACC=Rostral Anterior Cingulate Cortex, cACC=Caudal Anterior Cingulate Cortex 
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Table 8. Hierarchical linear regression predicting change in apathy severity 
  R R2 ΔR2 F β 
Step 1  .84 .7 .7** 19.12**  
 mHDRS change     .5** 
 AES baseline     .46** 
 Mean thickness     .14 
Step 2  .84 .71 .01 7.26**  
 mHDRS change     .54** 
 AES baseline     .41* 
 Mean thickness     .2 
 lOFC thickness     .05 
 mOFC thickness     -.08 
 rACC thickness     -.09 
 cACC thickness     -.04 
Note. N=29; *p<.05, **p<0.01; AES= Apathy Evaluation Scale; mHDRS=Hamilton Depression Rating Scale; 
lOFC=Lateral Orbitofrontal Cortex, mOFC=Medial Orbitofrontal Cortex, rACC=Rostral Anterior Cingulate Cortex, 
cACC=Caudal Anterior Cingulate Cortex 
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Graph 6. Scatterplot of RN ROIs and AES Change 
 
 
Note. N=29; AES=Apathy Evaluation Scale; lOFC=Lateral Orbitofrontal Cortex, mOFC=Medial Orbitofrontal 
Cortex, rACC=Rostral Anterior Cingulate Cortex, cACC=Caudal Anterior Cingulate Cortex 
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IV. COGNITIVE FUNCTIONING 
Table 9. Hierarchical linear regression predicting baseline apathy severity  
  R R2 ΔR2 F β 
Step 1  .22 .05 .05 1.54  
 mHDRS baseline     .22 
Step 2  .59 .35 .3 .79  
 mHDRS baseline     .06 
 HVLT IR baseline     .13 
 HVLT DR baseline     -.02 
 HVLT Persev baseline     -.08 
 HVLT Intru baseline     .06 
 HVLT TP baseline     -.28 
 HVLT FP baseline     -.15 
 Stroop Inter baseline     -.12 
 Trails A baseline     .01 
 Trails B baseline     -.3 
 WCST Cat baseline     -.58 
 WCST PersErr baseline     -.25 
 WCST FMS baseline     -.02 
Note. N=33; *p<.05, **p<0.01; mHDRS=Modified Hamilton Depression Rating Scale; HVLT=Hopkins Verbal 
Learning Test; IR=Immediate Recall; DR=Delayed Recall; Persev=Perseverative Errors; Intru=Intrusion Errors; 
TP=True Positives; FP=False Positives; Inter=Interference Score; WCST=Wisconsin Card Sorting Test; 
PersErr=Perseverative Errors; Cat=Categories Completed; FMS=Failure to Maintain Set 
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Table 10. Hierarchical linear regression predicting week 12 apathy severity 
  R R2 ΔR2 F β 
Step 1  .68 .46 .46** 15.23**  
 mHDRS week 12     .68** 
Step 2  .89 .78 .32 1.66  
 mHDRS week 12     .99* 
 HVLT IR week 12     -.74 
 HVLT DR week 12     .89 
 HVLT Persev week 12     .08 
 HVLT Intru week 12     -.73 
 HVLT TP week 12     -1.17 
 HVLT FP     .72 
 Stroop Inter week 12     .45 
 Trails A week 12     .01 
 Trails B week 12     -.53 
 WCST Cat week 12      -.2 
 WCST PersErr week 12     .44 
 WCST FMS week 12     .17 
Note. N=20; *p<.05, **p<0.01; mHDRS=Modified Hamilton Depression Rating Scale; HVLT=Hopkins Verbal 
Learning Test; IR=Immediate Recall; DR=Delayed Recall; Persev=Perseverative Errors; Intru=Intrusion Errors; 
TP=True Positives; FP=False Postivies; Inter=Interference Score; WCST=Wisconsin Card Sorting Test; 
PersErr=Perseverative Errors; Cat=Categories Completed; FMS=Failure to Maintain Set 
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Table 11. Hierarchical linear regression predicting change in apathy severity 
  R R2 ΔR2 F β 
Step 1  .74 .55 .55** 10.35**  
 mHDRS baseline     .43* 
 AES baseline     .43* 
Step 2  .99 .98 .43* 13.75**  
 mHDRS baseline     .59* 
 AES baseline     -.21 
 HVLT IR baseline     1.02* 
 HVLT DR baseline     -.99* 
 HVLT Persev baseline     -.3 
 HVLT Intru baseline     .18 
 HVLT TP baseline     -.61 
 HVLT FP baseline     -.53* 
 Stroop Inter baseline     .09 
 Trails A baseline     .64** 
 Trails B baseline     -.7** 
 WCST Cat baseline     -.24 
 WCST PersErr baseline     -.22 
 WCST FMS baseline     .38 
Note. N=20; *p<.05, **p<0.01; mHDRS=Modified Hamilton Depression Rating Scale; HVLT=Hopkins Verbal 
Learning Test; IR=Immediate Recall; DR=Delayed Recall; Persev=Perseverative Errors; Intru=Intrusion Errors; 
TP=True Positives; FP=False Postivies; Inter=Interference Score; WCST=Wisconsin Card Sorting Test; 
PersErr=Perseverative Errors; Cat=Categories Completed; FMS=Failure to Maintain Set 
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Table 12. Hierarchical linear regression predicting change in apathy severity 
  R R2 ΔR2 F β 
Step 1  .85 .73 .73** 27.91**  
 mHDRS baseline     .51** 
 AES baseline     .44** 
Step 2  .93 .87 .14 4.12*  
 mHDRS baseline     .47* 
 AES baseline     .47 
 HVLT IR week 12     .09 
 HVLT DR week 12     -.44 
 HVLT Persev week 12     .2 
 HVLT Intru week 12     -.27 
 HVLT TP week 12     .13 
 HVLT FP week 12     .01 
 Stroop Inter week 12     .19 
 Trails A week 12     -.11 
 Trails B week 12     -.00 
 WCST Cat week 12      -.43 
 WCST PersErr week 12     -.43 
 WCST FMS week 12     -.01 
Note. N=24; *p<.05, **p<0.01; AES= Apathy Evaluation Scale; mHDRS=Modified Hamilton Depression Rating 
Scale; HVLT=Hopkins Verbal Learning Test; IR=Immediate Recall; DR=Delayed Recall; Persev=Perseverative 
Errors; Intru=Intrusion Errors; TP=True Positives; FP=False Postivies; Inter=Interference Score; WCST=Wisconsin 
Card Sorting Test; PersErr=Perseverative Errors; Cat=Categories Completed; FMS=Failure to Maintain Set 
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APPENDIX B - FIGURES 
Figure 1. Differences and similarities between symptoms of apathy and depression  
Apathy Apathy and Depression Depression 
Decreased motivation 
Reduced emotional 
reactivity 
Blunted affect 
Poor initiation 
Lack of insight 
Indifference 
 
Decreased interest or pleasure 
Psychomotor retardation 
Anergia 
Social withdrawal 
 
Sad or depressed mood  
Irritability 
Guilt 
Feelings of worthlessness 
Hopelessness 
Helplessness 
Indecisiveness 
Suicidality 
Adapted from Marin 1991 
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Figure 2. Proposed diagnostic criteria for apathy 
For a diagnosis of apathy, criteria A, B, C, and D should be fulfilled 
A. Loss or diminished motivation in comparison to the patient’s previous level of functioning, 
either by self-report or observation 
B. Presence of at least one symptoms in at least two of the following three domains most of the 
time for at least four weeks  
Behavior Initiation: loss of self-initiated behavior 
Responsiveness: loss of environment-stimulated behavior 
Cognition Initiation: loss of spontaneous ideas and curiosity for routine and new events 
Responsiveness: loss of environment-stimulated ideas and curiosity for routine 
and new events 
Emotion Initiation: loss of spontaneous emotion, observed or self-report 
Responsiveness: loss of emotional responsiveness to positive or negative stimuli 
or event 
C. These symptoms cause clinically significant impairment in personal, social, occupational 
and/or other important areas of functioning 
D. These symptoms are not exclusively explained by physical disabilities, motor disabilities, 
diminished level of consciousness, or the direct physiological effects of a substance  
Adapted from Mulin et al., 2010 
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Figure 3. Key nodes in the Salience Network 
 
Note. ACC = Anterior Cingulate Cortex    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ACC 
Insula 
Coronal View Axial View 
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Figure 4. The Salience Network 
 
 
 
 
Note. AI = Anterior Insula; dACC = Dorsal Anterior Cingulate Cortex  
Adapted from Menon 2015 
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Figure 5. Key nodes in the Reward Network 
 
 
Sagittal View 
 
Note. ACC = Anterior Cingulate Cortex; OFC = Orbitofrontal Cortex 
Adapted from Klein and Tourville 2012 
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Figure 6. The Reward Network 
 
Note. OFC = Orbitofrontal Cortex; ACC = Anterior Cingulate Cortex 
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Figure 7. Incentive Salience Processing  
 
Note. AI = Anterior Insular; OFC = Orbitofrontal Cortex; ACC = Anterior Cingulate Cortex 
 
 
 
 
 
 
 
 
 
 	  	  	  
	  	  	  	  
109 
Figure 8. Cortical ROI parcellations in the Desikan-Killiany atlas  
 
 
From Klein and Tourville 2012 
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